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1.1 General Introduction  
;$/$! $X4($++,2/! ,+! '! 56/#'0$/)'&! 0$%*'/,+0! 25! )*$! &,5$w! )*(269*! ,)+! ),9*)!
($96&'),2/U!'&&!2(9'/,+0+!%2/)(2&!)*$,(!-,2&29,%'&!4(2%$++$+!SJ,0+!$)!'&7U!O[[YT7!
"/! '&&! <$)'Z2'/+! 9$/$),%! +)6#,$+! *'R$! +*2./! )*')! )*$! 9$/$+! %2#,/9! 52(! 4(2)$,/+!





*60'/! 9$/$+! '($! $/%2#$#! ,/! '-26)! 2/&1! P\! 25! )*$! 9$/20$U! .,)*! )*$! 2)*$(! KK\!
%2/)',/,/9!%204&$X! ,/+)(6%),2/+!)*')!#,($%)!)*$!,/)(,%')$!)6(/,/9!2/!'/#!255!25!9$/$!
)('/+%(,4),2/! SB&'04$ #.$ -2"U! O[[_T! SF$//,+,U! O[POT7! G*,+! +699$+)+! )*')! +4$%,5,%!
($96&')2(1! 0$%*'/,+0+! 06+)! 4(29('0! 4(29($++,R$&1! 02($! %204&$X! 2(9'/,+0+!
S=23'+U!O[[kT7!!
J4'),2D)$042('&! )6/,/9! 25! 9$/$! $X4($++,2/! 4'))$(/+! 6/#$(4,/+! %$&&D)14$! +4$%,5,%,)1!
,/!06&),%$&&6&'(!2(9'/,+0+!'/#!4(2-'-&1!6/#$(&,$+!0'/1!#,+$'+$!4(2%$++$+7!"/#$$#U!
0'/1!%$&&6&'(!4(2%$++$+!'($!3/2./!)2!%2/)(2&!9$/$!$X4($++,2/7!!
"/! $63'(12)$+U! )*$! =8I! )('/+%(,4),2/! ,+! )*$! 0',/! +)'9$! .*$($! 9$/$! ($96&'),2/!
2%%6(+7! G('/+%(,4),2/! %2/+,+)+! 25! '! +$(,$+! 25! #,+),/%)! '/#! %2/+$%6),R$! 4*'+$+f! 4($D
,/,),'),2/U! 4(202)$(! %&$'('/%$! '/#! ,/,),'),2/U! $&2/9'),2/! '/#! )$(0,/'),2/7! "/! '!
)('/+%(,4),2/! 4($D,/,),'),2/! 4*'+$U! +$R$('&! )('/+%(,4),2/! 5'%)2(+! SGAT! 4($%,+$&1!




"/,),'),2/! 25! =8I! +1/)*$+,+! ,+! 4($%$#$#! -1! )*$! 4(202)$(! $+%'4$U! )*$! 4(2%$++! ,/!
.*,%*!SZI,! ""! &$'R$+!-$*,/#! )*$!-6(#$/!25! +$R$('&!GA+U! $++$/),'&! ,/! )*$! 4($R,26+!
+)$4!S4(202)$(!%&$'('/%$!'/#!,/,),'),2/T7!I+!2-+$(R$#!,/!'!('/9$!25!9$/$+U!)*$!=8IF!




%'&&$#! F(202)$(! 4(2X,0'&! 4'6+,/9! 25! =8IF! ""U!0',/&1! #$4$/#+! 2/! )*$! '%),R,)1! 25!
).2! /$9'),R$! $&2/9'),2/! 5'%)2(+U! E=ND,/#6%$#! +),06&'),/9! 5'%)2(! SE"JAT! '/#! )*$!
/$9'),R$!$&2/9'),2/!5'%)2(!S8@?AT7!G*,+!($96&')2(1!0$%*'/,+0!%26&#!-$!$++$/),'&!)2!
'++$++! )*')! )*$!=8IF!""! ,+!4(24$(&1!42+,),2/$#!52(!4(2#6%),R$!$&2/9'),2/! Se'#'$ #.$
-2"U! PKKkw! C'0'96%*,$ #.$ -2"U! PKKKT7! "/! )*$,(! 4($+$/%$U! =8IF! ""! 2/&1! 52(0+! +*2()!
'-2()$#!)('/+%(,4)+7!G*$!,/)$(R$/),2/!25!)*$!F2+,),R$!G('/+%(,4),2/!@&2/9'),2/!A'%)2(!




I/2)*$(! 3$1! (2&$! ,/! )*$! 9$/$! ($96&'),2/! ,+! ($4($+$/)$#! -1! #1/'0,%! %*'/9$+U! '&+2!
%'&&$#! $4,9$/$),%! 0$%*'/,+0+U! 25! %*(20'),/7! G*$+$! '($! %*'('%)$(,Z$#! -1!
02#,5,%'),2/+! 25! *,+)2/$+U! !"#"! 0$)*1&'),2/U! 4*2+4*2(1&'),2/U! '%$)1&'),2/! '/#!
6-,:6,),/'),2/!Sa$/6.$,/!'/#!I&&,+U!O[[Pw!J)('*&!'/#!I&&,+U!O[[[T7!!
1.2.  Cycl in-dependent kinases 
B$&&! #,R,+,2/! '/#! #,55$($/),'),2/! '($! ),9*)&1! %2/)(2&&$#! 4(2%$++$+U! 4'(),%6&'(&1! ,/!
06&),%$&&6&'(! 2(9'/,+0+! )*')! /$$#! '! 4($%,+$! %22(#,/'),2/! 25!06&),4&$! %$&&! )14$+! ,/!
#,55$($/)! ),++6$+! S<'&60-($+U! O[PPT7! A,(+)! +)6#,$+!25! %$&&! #,R,+,2/!0$%*'/,+0+!#')$!
-'%3!)2!)*$!9$/$),%!+%($$/+!,/!1$'+)!SL'().$&&U!PK_Yw!86(+$U!PK_Vw!86(+$U!O[[[T!.*$/!
+$R$('&! %$&&! #,R,+,2/! %1%&$! SB#%T!9$/$+!.$($! ($%29/,Z$#!'+!3$1! 4&'1$(+! )*(269*26)!
)*$! %$&&! %1%&$! S<'&60-($+U! O[PPw! <'&60-($+! '/#! N'(-'%,#U! O[[KT7! G*$! /60-$(! 25!











R,'! )*$,(! 6-,:6,)26+! 4*2+4*2(1&'),2/! ($'%),2/+! S<2(9'/U! PKKVT7! <2+)! 25! BEH+!
($:6,($! -,/#,/9! 4'()/$(+! %'&&$#! %1%&,/+! )*')! +$(R$! '+! ($96&')2(1! +6-6/,)+7! J20$!
BEH+! %'/! -$! '%),R')$#! -1! +$R$('&! )14$+! 25! %1%&,/+U! .*$($'+! 2)*$(+! 2/&1! '++2%,')$!
.,)*!2/$!+4$%,5,%!%1%&,/7!
J2! 5'(U! O[!BEH+!'($!3/2./!'/#U! #$+4,)$! )*$!*,9*! &$R$&!25! +$:6$/%$!'/#! +)(6%)6('&!
*202&291! -$).$$/! )*$0U! $'%*! BEH! +$$0+! )2! -$! ,/R2&R$#! ,/! #,55$($/)! %$&&6&'(!
4(2%$++$+!S;24,/')*'/$#.$-2"U!O[PPTU!0',/&1!%$&&!%1%&$!'/#!=8I!)('/+%(,4),2/7!
1.2.1 Cyclin dependent kinases: Role in the 
Regulat ion of the Cell Cycle and Transcr ipt ion 
J20$!BEHl%1%&,/!%204&$X$+!'($!#,($%)&1!,/R2&R$#!,/!#(,R,/9!)*$!%$&&!%1%&$7!I02/9!
)*$+$U!BEHP!,+!,/R2&R$#!,/!)*$!0,)2+,+U!BEHOU!BEHY!'/#!BEH]!'($!,/)$(4*'+,%!'/#!
'($!'++2%,')$#!.,)*! )$/! %1%&,/+!25! )14$!IDU!NDU!ED!'/#!@! S<'&60-($+!'/#!N'(-'%,#U!
O[[_w!<'&60-($+$ #.$ -2"U! O[[kT7! >)*$(! BEH!0$0-$(+!02#$(')$&1! ,04&,%')$#! ,/! )*$!





*142)*$+,Z$#! )*')! )*,+! #6'&! (2&$!25!BEH_!0'1!4(202)$! )*$! %264&,/9!25! )*$+$! ).2!
4(2%$++$+!#6(,/9!%$&&!%1%&$!4(29($++,2/!S?21$($#.$-2"U!O[[VT7%
I! /60-$(! 25! BEH! 5'0,&1! 0$0-$(+U! ,/! 4'(),%6&'(! BEH_U! BEHk! '/#! BEHKU! *'R$!
-$$/! +*2./! )2! -$! 0',/&1! ,/R2&R$#! ,/! )('/+%(,4),2/'&! ($96&'),2/! '/#! 0=8I!
4(2%$++,/9!S<$,Q$(!'/#!='102/#U!O[[jw!F($&,%*U!O[[Ow!^$(0$6&$/$#.$-2"U!O[[jT7!G*$+$!
$/Z10$+! '($! $R2&6),2/'(,&1! %2/+$(R$#! 5(20! 1$'+)! )2! 0'00'&+U! '/#! '&&! )*($$! '($!
%2042/$/)+!25!#,55$($/)!4(2)$,/!%204&$X$+7!BEH_!S%'&&$#!H,/Ok!,/!1$'+)T!,+!'!4'()!25!
)*$! )('/+%(,4),2/! 5'%)2(!GA""L! S>(4*'/,#$+$ #.$ -2"U! PKK]T7! BEH_W%1%&,/!L! %204&$X$+!
'($! ,04&,%')$#! ,/! )*$! ,/,),'),2/! 4*'+$! 25! )('/+%(,4),2/U! !"#"! ,/! )*$! %&$'('/%$! 25! )*$!
4(202)$(!'/#!)*$/!,/!)*$!4(29($++,2/!25!)('/+%(,4),2/!52&&2.,/9!4*2+4*2(1&'),2/!25!





BEHk! '++2%,')$+! .,)*! %1%&,/! B! ,/! )*$! J(-W<$#,')2(! %204&$X! SI326&,)%*$R$ #.$ -2"U!
O[[[T! '/#! 56/%),2/+! ,/! )('/+%(,4),2/'&! $R$/)+! 4(,2(! )2! $&2/9'),2/! SB*2$ #.$ -2"U! PKKkT7!
=$%$/)&1U! BEHk! *'+! -$$/! +*2./! )2! ,/#6%$! %2&2/! %'/%$(! -1! '! 9$/$! '04&,5,%'),2/!
0$%*'/,+0!SA,($+)$,/$#.$-2"U!O[[kT7!!
G*$! )*,(#! 3,/'+$U! BEHKU! ,+! 4'()! 25! FDG@A-! %204&$X! SM*6$ #.$ -2"U! PKK_T! '/#U! '+! )*$!
0',/! +6-Q$%)! 25! )*,+! )*$+,+U! .,&&! -$! #,+%6++$#! ,/! 02($! #$)',&+! ,/! )*$! 52&&2.,/9!
%*'4)$(+!'/#!+$%),2/+7!!
BEHP[!'/#!BEHPP!'&+2!#,+4&'1!)*$,(!(2&$+!,/!($96&'),/9!)('/+%(,4),2/!'/#!)*$!;OW<!
4*'+$! 25! )('/+,),2/! ,/! )*$! %$&&! %1%&$! S<'&60-($+! '/#! N'(-'%,#U! O[[VT7! BEHPO! '/#!
BEHPjU!,/!'++2%,'),2/!.,)*!?D)14$!%1%&,/+U!($96&')$!'&)$(/'),R$!+4&,%,/9!SB*$/$#.$-2"U!
O[[]w!B*$/$ #.$ -2"U! O[[_T7! BEHPY! )2!BEHPk! 4&'1! +4$%,5,%! 56/%),2/+! ,/! )*$! %2/)(2&!25!
#,R$(+$! %$&&6&'(! 4(2%$++$+U! '&)*269*! )*$! ($&$R'/%$! 25! )*$+$! 3,/'+$+! ,+! 02+)&1!
6/3/2./!S;24,/')*'/$#.$-2"U!O[PPw!<'&60-($+U!O[PPT7!N$%'6+$!25!)*$!,042()'/%$!25!
)*$!BEH+! ,/!0'/1! %$&&6&'(! 4(2%$++$+U! )*$1! ($:6,($! '! ),9*)! ($96&'),2/7!<$0-$(+!25!
)*$! "/3Y! '/#! B,4WH,4! 5'0,&1! '($! '02/9! )*$! 02+)! ,042()'/)! $/#29$/26+! BEH!
,/*,-,)2(+!SBH"+T!SJ*$((!'/#!=2-$()+U!PKKVT7!!
1.3 Cycl in-dependent kinase 9 
I02/9!'&&!)*$!BEH+U!BEHK!*'+!-$$/!+*2./!)2!-$!'/!,042()'/)!($96&')2(1!02&$%6&$!
)*')!%26&#!'%)!'+!'! &,/3,/9!/2#$!25!+$R$('&!#,+$'+$+U!L"^!'/#!%'(#,'%!*14$()(24*1U!
Q6+)! )2! 0$/),2/! '! 5$.! SH(1+)25$ #.$ -2"U! O[P[T7! ")+! +)(6%)6($U! -,2&29,%'&! 56/%),2/U! '/#!
$+4$%,'&&1! ,)+! ,/R2&R$0$/)! ,/! %'(#,'%! #$R$&240$/)U! 9(2.)*! '/#! 56/%),2/! '($!
#,+%6++$#!,/!#$)',&!,/!)*$!52&&2.,/9!+$%),2/+7!J$4'(')$!+$%),2/+!'($!#$R2)$#!)2!BEHK!
02&$%6&'(!,/*,-,)2(+!'/#!)*$,(!4*'(0'%2&29,%'&!02#6&'),2/7!!
1.3.1 CDK9: Molecular structure and isoforms 
A2&&2.,/9! '! +%($$/,/9! ',0$#! )2! ,+2&'),/9! 5'%)2(+! ,/R2&R$#! ,/! )*$! 0'00'&,'/! %$&&!






26(! 3/2.&$#9$! 25! )*,+! /$.! 5'%)2(7! ")! ,+! 3/2./! )*')! %1%&,/! G! 2(! H! ,+! )*$! -,/#,/9!
4'()/$(!SF$/9$#.$-2"U!PKKkw!M*6$#.$-2"U!PKK_w!e$,$#.$-2"U!PKKkT7!L60'/!BEHK!9$/$!0'4+!
)2! %*(202+20$! K:jY7P! SN6&&(,%*$ #.$ -2"U! PKKVT! '/#! ,+! %2042+$#! 25! +,X! ,/)(2/+! '/#!
%2/)(2&&$#!-1!'!GIGID&$++!*26+$3$$4,/9!4(202)$(! S?,6!'/#!=,%$U!O[[[T7!<2&$%6&'(!
+)(6%)6($! 25! BEHK! 4(2)$,/! ,/%&6#$+! '! 3,/'+$! 52&#! %204(,+,/9! 8D! '/#! BD)$(0,/'&!
&2-$+!SN'60&,$#.$-2"U!O[[kT!'/#!'!G!&224!+)(6%)6($!52(!)*$!'%%$++!25!)*$!IGF!+6-+)(')$!
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1.3.2 CDK9: Dif ferential expression and distr ibution  
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1.3.4 CDK9: activat ion and regulation 
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1.3.5 CDK9: effects on the transcription 
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1.3.6 CDK9: role in the heart 
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1.4 CDK9 as a therapeutic target in human 
diseases 
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1.4.1 The ro le of CDK9 in Oncology 
A2(!4(2&,5$('),R$!#,+2(#$(!)*$('4,$+U!)*$!#$R$&240$/)!25!'/),%'/%$(!'9$/)+!)'(9$),/9!
)*$!%$&&!%1%&$U!($4($+$/)+!'!R,'-&$!+)(')$91!Se'/9!'/#!A,+%*$(U!O[[kT7!"/#$$#U!BEH+!
02#6&'),2/! ,/! %'/%$(! *'+! 9')*$($#! 9($')! ,/)$($+)! SN21$(! '/#! B*$/9U! O[[kw!
<'&60-($+! '/#! N'(-'%,#U! O[[Vw! <'&60-($+! '/#! N'(-'%,#U! O[[_T7! E$($96&'),2/! 25!
BEHK!4')*.'1+!0'1!-$!,/R2&R$#!,/!)*$!2(,9,/!'/#!0',/)$/'/%$!25!)('/+52(0$#!%$&&!
4*$/2)14$! SN$&&'/$ #.$ -2"U! O[[Yw! ;'/$ #.$ -2"U! O[[jT7! BEHKD($&')$#! 4')*.'1! ,0-'&'/%$!
*'+! -$$/! ($42()$#! ,/! +$R$('&! *60'/! )602(+f! /$6(2-&'+)20'! '/#! &104*20'+!
SN$))'1$-$#.$-2"U!O[[_w!A6$#.$-2"U!PKKKTU!4(,0'(1!/$6(2$%)2#$(0'&!)602(!SE$!A'&%2!'/#!
;,2(#'/2U! O[[OTU! (*'-#2012+'(%20'! SJ,02/$! '/#! ;,2(#'/2U! O[[_T! '/#! 4(2+)')$!
%'/%$(!S?$$$#.$-2"U!O[[PT7!!
1.4.2 The ro le of CDK9 in Virology 
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1.4.3 The ro le of CDK9 in Heart Fai lure  
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1.5.  Zebrafish: Model of medical research  
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1.5.1. A fascinating new vertebrate model 
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1.5.2 Advantages of the zebrafish as a model 
organism 
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1.5.3 Genetic Intervention: Morpholino antisense 
gene knock-down technology 
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1.5.3.1 Controls MO 
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1.5.3.2  Rescue MO 
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1.5.4 Zebrafish embryo as a model of cardiac 
disease 
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1.5.5 Assessment of cardiac function 
J$R$('&!0$)*2#+!*'R$!-$$/!4(242+$#!)2!'++$++!%'(#,'%!56/%),2/!,/!)*$!Z$-('5,+*!'/#!
$'%*!25!)*$0!4($+$/)!4(2+!'/#!%2/+7!






I!0$)*2#! 02($! +6,)'-&$! 52(! $0-(12+! '++60$+! )*')! )*$! Z$-('5,+*! R$/)(,%&$! %'/! -$!
($4($+$/)$#! -1! '! )*($$D#,0$/+,2/'&! 5,96($! +6%*! '+! '! 4(2&')$! +4*$(2,#! SL26! '/#!
N6(99($/U! PKKVw! J*,/$ #.$ -2"U! O[P[T7! G*$! ($&')$#! +)'/#'(#! 52(06&'! 52(! )*$! R2&60$!
$04&21+!&2/9!'/#!+*2()D'X,+!R$/)(,%6&'(!4&'/$+7!!
e*$($'+! )*$! J,04+2/d+! 0$)*2#U! '&+2! %'&&$#! 0$)*2#! 25! #,+%+U! '++60$+! )*')!
R$/)(,%6&'(! R2&60$! ,+! )*$! +60! 25! )*$! R2&60$+! 25! ,/#,R,#6'&! #,+%+! ,/)2!.*,%*! )*$!
R$/)(,%&$!%'/!-$!+&,%$#!SB26%$&2!'/#!a2':6,0U!O[[[T7!"/!)*$!%&,/,%'&!+$)),/9U!R$/)(,%&$!
$Q$%),2/! 5('%),2/! ,+! #$5,/$#! '+! )*$! 5('%),2/'&! R2&60$! 25! -&22#! $Q$%)$#! -1! )*$! &$5)!
R$/)(,%&$! #6(,/9! $'%*! %'(#,'%! %1%&$! SE2(2+Z$ #.$ -2"U! O[POT! '/#! ,)! ,+! )('#,),2/'&&1!
'++$++$#! $%*2%'(#,29('4*,%'&&1! .,)*! )*$! 0$)*2#! 25! #,+%+! SA2&&'/#$ #.$ -2"U! PK_KT7!
L2.$R$(U! )*,+!0$)*2#! ,+!+6-Q$%)! )2!$((2(+!#6$!)2! 52($+*2()$/,/9U!422(!$/#2%'(#,'&!
#$5,/,),2/U!/'((2.!$%*2%'(#,29('4*,%!.,/#2.+U! '/#!'++604),2/+!'-26)! ?^! +*'4$7!
<2($2R$(U!-1!)*$!$55$%)!25!)*$!4(24'9'),2/!25!6/%$()',/),$+U!)*$!$((2(!%200,))$#!,/!
)*$!%'&%6&'),2/!25!'!R2&60$!.,&&!-$!*,9*$(!.*$/!%204'($#!)2!'/!'($'D-'+$#!52(06&'7!
8$R$()*$&$++U! )*,+! ,+! )*$!0$)*2#! )*')! +$R$('&! '6)*2(+! 6+$! ,/! )*$! Z$-('5,+*! $0-(12!
SI/)3,$.,%Z$#.$-2"U!O[[]w!H,0$#.$-2"U!O[[_T7!
"/! )*,+! )*$+,+U! )*$! A('%),2/'&! I($'! B*'/9$! 25! )*$! ^$/)(,%&$U! )*')! *$($! .$! +,04&1!
%'&&$#! @Q$%),2/! A('%),2/! S@ATU! .'+! 6+$#! )2! '++$++! %'(#,'%! 4$(52(0'/%$! ,/! )*$!
Z$-('5,+*! $0-(127! G*,+! 0$)*2#! *'+! -$$/! 4($5$(($#! '/#! '#24)$#! ,/! )*,+! )*$+,+!
-$%'6+$! ,)! .'+! 4('%),%'&! '/#! *,9*&1! ($4(2#6%,-&$! '/#! *'+! -$$/! '&($'#1! 6+$#! ,/!
4($R,26+! $X4$(,0$/)+! .,)*! )*$! Z$-('5,+*! $0-(12! ,/! 26(! "/+),)6)$! SH<! L'0,&)2/D
J0,)*U!F*E! )*$+,+T7! ")! ,+! ,042()'/)! )2!/2)$! )*')! )*$+$! #')'! +$(R$#!/2)! )2! '++$++! )*$!
'-+2&6)$! %'(#,'%! 4$(52(0'/%$! -6)! $X%&6+,R$&1! )2! %204'($! %2/)(2&! .,)*! )($')$#!
9(264+! 25! $0-(127! I! +,0,&'(! 0$)*2#! *'+! -$$/! 4($R,26+&1! 6+$#! ,/! )*$! Z$-('5,+*!
$0-(12! SJ*6$ #.$ -2"U! O[[jTU! '&)*269*! )*$! '6)*2(+! 6+$#! R$/)(,%&$! &2/9D'X,+! &$/9)*!
,/+)$'#!25!)*$!'($'7!G*$!5('%),2/'&!'($'!%*'/9$!*'+!-$$/!6+$#!,/!*60'/!S=21+$!'/#!
=21+$U!O[[[TU!0',/&1!52(!($+$'(%*!46(42+$+U!52(!:6'/),51,/9!%*'/9$+!,/!)*$!+*2()D'X,+!
,0'9$! 25! )*$! &$5)! R$/)(,%&$! SE20'/+3,$ #.$ -2"U! PKKOT7! G*$! 5('%),2/'&! '($'! %*'/9$! ,+!
'++$++$#! -1! 0'/6'&! 4&'/,0$)(1! 25! )*$! '($'! %,(%60+%(,-$#! -1! )*$! $/#2%'(#,60! ')!





G*$!0$)*2#!*'+!-$$/! R'&,#')$#! ,/!2/$! +)6#1!.*,%*! %204'($#! ('#,2/6%&,#$! -&22#!
422&! ,0'9,/9! .,)*! )('/+$+24*'9$'&! $%*2%'(#,29('4*1! '($'! $Q$%),2/! 5('%),2/!
Sb(-'/2.,%Z$#.$-2"U!PKK[T7!
1.6.  Early cardiac development in vertebrates 
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1.7.  Cardiomyocyte prol i ferat ion: hyperplasia 
versus hypertrophy  
1.7.1 Dur ing cardiac development 
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1.7.2. Transit ion from the fetal to the adult l i fe 
e*,&$!%'(#,2012%1)$+!#,R,#$!$X)$/+,R$&1!'/#!('4,#&1!#6(,/9!5$)'&!&,5$!)*$1!&2+$!)*$!
4(2&,5$('),R$! %'4'%,)1! +*2()&1! '5)$(! -,()*! ,/! (2#$/)+7! L2.$R$(U! F2(($&&2! '/#!
%2&&$'96$+!SF2(($&&2$#.$-2"U!O[PPT!*'R$!+*2./!)*')!/$2/')'&!026+$!%'(#,2012%1)$!/2)!
2/&1! %2/),/6$! )2!4(2&,5$(')$! 52(! 64! )2!2/$!.$$3! '5)$(!-,()*U! )*$1!'&+2! %2/+$(R$! )*$!
%'4'%,)1!)2!($9$/$(')$!)*$!%'(#,'%!'4$X!52&&2.,/9!+6(9,%'&!($+$%),2/7!G*,+!5,/#,/9!*'+!
($D$/$(9,Z$#! )*$! +$'(%*! 52(! 0$%*'/,+0+! )*')! 6/#$(4,/! %$&&! %1%&$! '(($+)! ,/! )*$!
0'00'&,'/! *$'()!.,)*! )*$! ,/)$/),2/!25!46(+6,/9!3$1!02&$%6&'(! )'(9$)+! )*')!0,9*)!
,/#6%$!0')6($!0'00'&,'/!%'(#,2012%1)$+!)2!($D$/)$(!)*$!%$&&!%1%&$7!!
"/! *60'/+U! %'(#,2012%1)$! 4(2&,5$('),R$! %'4'%,)1! ,+! &2+)! ')! 5$.!02/)*+! '5)$(! -,()*!
.*$/! )*$1! .,)*#('.! 5(20! )*$! %$&&! %1%&$! '/#! ($0',/! ,/! ;[! +)'9$! '44'($/)&1!
,/#$5,/,)$&1! SF22&0'/! '/#! N(223+U! PKKkw! N6+3! '/#! L,/(,%*+$/U! O[[jw! @/9$&U! O[[Vw!
N,%3/$&&$#.$-2"U!O[[_T7!"/!'##,),2/U!%$&&!%1%&$!'44$'(+!%&2+$&1!%264&$#!)2!'%%606&'),2/!
25! %$&&! 0'++! #6(,/9! #$R$&240$/)U! ,/! 2(#$(! )2! 0',/)',/! %2/+,+)$/%1! 25! %$&&! +,Z$!
S8$65$&#! '/#! @#9'(U! PKKkT7! "/! 02+)! +4$%,$+U! )*,+! *14$(4&'+),%D)2D*14$()(24*,%!
)('/+,),2/! ,+!%*'('%)$(,Z$#!-1!%*'/9$+! ,/!#$9($$!25!4&2,#1!'/#!/60-$(!25!/6%&$,!'+!
%'(#,2012%1)$+! 6/#$(92! '##,),2/'&! E8I! ($4&,%'),2/! 52&&2.$#! -1! %1)23,/$+,+!
'/#W2(! 3'(123,/$+,+! S?,$ #.$ -2"U! PKK]w! ?,$ #.$ -2"U! PKKkT7! A2(! $X'04&$U!0'00'&,'/! 5$)'&!
%'(#,2012%1)$+U! ,/%&6#,/9! *60'/! *'R$! '! +,/9&$! /6%&$6+! .,)*! '! #,4&2,#! 9$/20$!
SO/T7!e*,&$!'#6&)!*60'/!%'(#,2012%1)$+!'($!02+)&1!02/2/6%&$')$#!'/#!)$)('4&2,#!
SY/T! '/#! '#6&)! 0,%$! %'(#,2012%1)$+! '($! 0',/&1! -,/6%&$')$#! '/#! #,4&2,#! SO/T!
S?'5&'00$! '/#! <6((1U! O[PPT7! "/#$$#U! +$R$('&! ($42()+! *'R$! +*2./! '! 9('#6'&!
#$%($'+$!,/!)*$!,/%2(42('),2/!25!('#,2&'-$&$#!)*10,#,/$!+22/!'5)$(!-,()*U!%2,/%,#$/)!
.,)*! )*$! 52(0'),2/! 25! -,/6%&$')$#! %'(#,2012%1)$+! ,/! 0,%$! SJ22/4''$ #.$ -2"U! PKK]w!
B&6--! '/#! N,+*24U! PKkYT7! G*,+! 4(2%$++! ,+! '++2%,')$#! .,)*! '/! $R,#$/)! ,/%($'+$! ,/!





1.7.3. During adulthood 
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1.7.4 Mammals versus Zebraf ish 
I#6&)!0'00'&,'/!%'(#,2012%1)$+!'-,&,)1!)2!($D$/)$(!)*$!%$&&!%1%&$!'/#!4(2&,5$(')$!,+!
R$(1!&,0,)$#!,/!%204'(,+2/!.,)*!&2.$(!R$()$-(')$+U!,/%&6#,/9!5,+*!S<'(),/DF6,9$#.$-2"U!
O[POT7! G*$! 6/#$(&1,/9! 02&$%6&'(! 0$%*'/,+0+! 4$(0,)),/9! 4(2&,5$('),2/! ,/! &2.$(!






%'(#,2012%1)$+! #2! /2)! 6/#$(92! '%1)23,/$),%! 0,)2+,+7! "/! 5'%)! )*$! 0'Q2(,)1! 25!
%'(#,2012%1)$+! ,/!'#6&)!Z$-('5,+*! %2/),/6$!)2!*'R$!'! +,/9&$!/6%&$6+!'/#!'!#,4&2,#!
9$/20$!SO/T!'/#!+*2.!+,9/,5,%'/)!4(2&,5$('),R$!'-,&,)1!Se,&&+$#.$-2"U!O[[kT7!!
G*$($52($U! '! 3$1! 4&'%$! )2! +)'()! )2! 6/#$(+)'/#! 0'00'&,'/! %'(#,2012%1)$!
4(2&,5$('),2/! ,+! #6(,/9! ,/D6)$(2! 9(2.)*! '/#! #$R$&240$/)! 25! )*$! *$'()! '/#! ,/! )*$!
4$(,/')'&!4$(,2#U!+)6#1,/9!)*$!4(2%$++$+! )*')!6/#$(&,$!%'(#,2012%1)$!$X,)! 5(20!)*$!
%$&&! %1%&$7! G*,+!0'1! *$&4! 6+! 6/#$(+)'/#! )*$!0$%*'/,+0! ($+42/+,-&$! 52(! #$5,/,),R$!
'(($+)!25!%$&&!%1%&$!,/!'#6&)!%'(#,2012%1)$+7!"/)$($+),/9&1U!N$%3$(!$)!'&7!SN$%3$($#.$-2"U!
O[PPT!%($')$#!'/#!'/'&1+$#!'!Z$-('5,+*!$0-(12!($42(),/9!'!06)'),2/!,/!)*$!)(242/,/!
S)//)OT! 9$/$U! )*')! %'6+$! *14$()(24*,%! %'(#,20124')*1! SLB<T! ,/! 0'00'&+7!
I&)*269*!)*$!9$/$!$X4($++,2/!4'))$(/!'/#!+'(%20$(,%!2(9'/,Z'),2/!.$($!+,0,&'(! )2!
)*2+$! 2-+$(R$#! ,/! *60'/+! '/#! 026+$! 02#$&+! .,)*! LB<U! )*$+$! 02(4*'/)+!
$X*,-,)$#!'!*14$(4&'+),%U!(')*$(!)*'/!*14$()(24*,%U!012%'(#,'&!($+42/+$7!!
b&),0')$&1U! '! #$)',&$#! 6/#$(+)'/#,/9! 25! )*$! 4')*.'1+! '/#! 4(2%$++$+! ,/R2&R$#! ,/!
%'(#,2012%1)$! #,55$($/),'),2/U! 0,9('),2/! '/#! 9(2.)*! 0'1! *$&4! )2! *'(/$++!
%'(#,2012%1)$! 4(2&,5$('),2/! '+! '! )*$('41! 52(! *60'/! #,+$'+$+! '++2%,')$#! .,)*!
+,9/,5,%'/)!%'(#,2012%1)$!&2++7!
B$&&! %1%&$! 4(202)$(+U! +6%*! '+! BEH+U! %1%&,/+U! '/#! 4(2)2D2/%29$/$+! '($! 0'(3$#&1!
$X4($++$#! ,/! $0-(12/,%! *$'()+U! %2(($+42/#,/9! )2! *,9*! %'(#,2012%1)$! %$&&! %1%&$!
'%),R,)1U!.*,&$!)*$,(!$X4($++,2/!,+! &2.$(! ,/!)*$!'#6&)!*$'()7!"/!9$/$('&U!/$9'),R$!%$&&!
%1%&$! ($96&')2(1! 9$/$+! '($! 64($96&')$#U! +6%*! '+! BEH+! ,/*,-,)2(+U! ,/! '#6&)! *$'()+U!
.*$($! %'(#,2012%1)$! %$&&! %1%&$! '%),R,)1! ,+! $X)($0$&1! &2.! SF'+60'()*,! '/#! A,$&#U!
O[[OT7! G*$+$! 3$1! 2-+$(R'),2/+! 4(2R,#$! '! %&$'(! ('),2/'&$! 52(! $X4&2('),2/! 25! )*$!
56/#'0$/)'&!4')*.'1+!'++2%,')$#!.,)*!BEHK!,/!)*$!*$'()!'/#!+6442()!)*$!/$$#!52(!
56()*$(!$&6%,#'),2/!,/!($&$R'/)!'/,0'&!02#$&+7!!
G*6+U! '&)*269*! )*$($! ,+! &,))&$! $R,#$/%$! )*$! Z$-('5,+*! $0-(12! 2(! '#6&)! 5,+*! '%)6'&&1!
+*2.+! %'(#,2012%1)$! *14$()(24*1U! ,)! #2$+! '44$'(! )2! #$02/+)(')$! '! *14$(4&'+),%!






1.8.  Response to Injury in the adult heart 
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1.8.1 Response to Heart In jury in Mammals 
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1.8.2 Models of Heart In jury in Mammals 
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1.8.3 Models of Heart In jury in Lower Vertebrates 
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1.9.  Heart regeneration mechanisms 
1.9.1. Mammalian regenerat ion 
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1.10 Hypothesis and Aims 
1.10.1 Hypothesis 
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2.1 Zebrafish, A(SP)Act 1986 and Ethical  Review  
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2.2 Husbandry, Breeding and Egg col lections 
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2.3 Zebrafish l ines 
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2.4 Anaesthesia and Euthanasia 
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2.5 Microscopy  
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2.5.1 Mounting technique for imaging 
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Figure 2.1 - Transgenic cardiac myosin light chain (cmlc)2:EGFP zebrafish embryo. A. The embryo, 
here shown at age 72 hpf has a length of about 3mm at this stage. Its transparency, in conjunction 
with utilization of fluorescent technology to mark organ or tissue specific signaling proteins or cellular 
entities, allows for powerful imaging of organ development. In this transgenic line expressing Green 
Fluorescent Protein (GFP) under the control of the cardiac specific cardiomyosin light chain 2 
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2.5.3 Compound microscopy and Fluorescence 
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2.5.4 Confocal microscopy  
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2.6 Evaluation of  Cardiac Function 
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2.6.2 Analysis of Ejection Fract ion 
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Figure 2.2 - Assessment of Ejection Fraction in the zebrafish embryonic heart. A. Black and white 
images, captured under fluorescence microscopy, of zebrafish embryo heart ventricle in end-diastole 
(left image) and end-systole (right image) in the same cardiac cycle, selected from a video of a 
cmlc2:EGFP zebrafish embryonic heart (72 hpf). B. Schematic representation showing the ventricular 
area in end-systole (dark red stripes) subtracted from the area in end-diastole (light red stripes) for 
calculating the Area Fractional shortening, in this context called Ejection Fraction. BA=bulbus 
arteriosus.  
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2.6.3 Heart Rate 




2.6.4 Cardinal vein blood velocity 
N&22#!R$&2%,)1!.'+!$+),0')$#!,/!)*$!42+)$(,2(!%'(#,/'&!R$,/!S"+29',$#.$-2"U!O[[Pw!=,#$($
#.$ -2"U! O[POT! -1! '++$++,/9! 5('0$! -1! 5('0$!02),2/! 25! +,/9&$! -&22#! %$&&+! #$)$(0,/$#!
5(20!R,#$2!,0'9$+!%'4)6($#!'+!#$+%(,-$#!,/!+$%),2/!O7]7P!,/!)*$!Z$-('5,+*!)',&!')!)*$!
&$R$&!25!)*$!%&2'%'!S+$$!5,96($!O7jT7!A26(!$(1)*(2%1)$+!4$(!5,+*!S')!&$'+)!Y!$0-(12+!4$(!








Figure 2.3 - Analysis of cardinal vein blood velocity in the zebrafish embryo. From 
a video (at 30 fps) captured in the zebrafish embryo tail at the level of the cloaca, 
the path of single blood cells was followed over 10 consecutive frames in the 
posterior cardinal vein. Video frames were analyzed using ImageJ, previously 
calibrated with a slide graticule of 1mm length. Blood cell velocity corresponded to 
the distance from the first to the tenth frame and was expressed as µm"s#1. Key: 
DA – Dorsal aorta, PCV – Posterior Cardinal Vein, Cr – Cranial, C – Caudal, D – 














2.7 Laser Injury Model 
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Figure 2.4 - Laser injury protocol using the Zeiss PALM® Laser. A. Membrane slides 1.0 PET (image 
from https://www.micro-shop.zeiss.com) were used in our laser injury protocol in order to check the 
efficiency of the laser beam before the start of each experiment. Following laser beam delivery on the 
slide film, this shows typically a 20-30!m diameter burn (B). C. Zebrafish embryos at age 72 hpf were 
laid on their left side on the membrane slide and a single laser beam was delivered in the mid-
ventricle (image D, obtained using an objective 20X) in correspondence of the blue spot in the green 
cross of the PALM system. (BA= bulbus arteriosus; V=ventricle; At= atrium).   
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2.7.2.1 XYClone laser ablator 
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Figure 2.5 – Laser injury of the zebrafish embryonic heart (aged 72 hpf) using Infrared Laser Ablator 
XYClone (Hamilton-Thorne). A. Isotherm Rings is a tool included in the software associated with the 
XYClone laser ablator, that provide the user with information related to the temperature reached in the 
injured tissue area and also help prevent potential harmful effects during the injury (Image from 
www.hamiltonthorne.com). B. Sequence of images selected from a video captured with a video 
camera associated with the microscope showing a typical event of cardiac laser injury, before laser 
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2.7.2.2 Optical Gating System 
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2.8 Isolation of zebrafish embryonic hearts 
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2.8.2 Mechanical-agitat ion method for extract ion of 
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Figure 2.6 - Techniques for isolation of zebrafish embryonic hearts. A. For immunohistochemical 
staining purpose, cmlc2:EGFP heart (in this image at 96 hpf) were fixated in PFA 4% and then 
microdissected singularly, suspended in PBS, under a fluorescent microscope. This approach 
preserves the integrity of the heart morphology and structure. B. Mechanical agitation method was 
used for high throughput hearts extraction needed, e.g., to obtain a proper RNA yield to perform PCR 
analysis: 1) embryos in EDM are drawn and expelled several times into and from a syringe in a 
microfuge, then 2) the liquid was applied to a 100µm nylon mesh (image from 
http://www.bdbiosciences.com) in a Petri dish to elute hearts, 3) the eluted was then applied to a 
40µm nylon mesh (image from http://www.bdbiosciences.com) to separate debris from the hearts. 
Retained material was washed off from the strainer into a clean dish and 4) GFP positive hearts were 
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Figure 2.7. BrdU staining on whole mount zebrafish embryo. Two images captured under fluorescence 
microscopy corresponding to the cranial (right) and caudal (left) ends of the embryo, here at age 96 
hpf. Red spots following immunostaining are BrdU positive nuclei and correspond to cell undergoing 
DNA replication. BrdU analysis using ImageJ software was assessed by counting red spots in the 
region of interest delimited by white squares and corresponding to an area of 10,000 !m2. 
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F*2+4*2L,+)2/$!Lj!SFLLjT!+)',/,/9!.'+!4$(52(0$#!)2!2-+$(R$!0,)2+,+!.*,&$!EIF"!
&'-$&&,/9!.'+!6+$#!)2!%26/)!)*$!)2)'&!/60-$(!25!R$/)(,%&$!42+,),R$!/6%&$,!,/!,+2&')$#!
*$'()+7! M$-('5,+*! %'(#,2012%1)$+! '($! 02/2/6%&$')$#U! )*$($52($! $'%*! FLLjD! 2(!
EIF"D42+,),R$!/6%&$6+!.'+!%2/+,#$($#!2/$!%'(#,2012%1)$7!!
%0&%Of@;AFW;IGIPf#+=$#! %(2++$#! &,/$! .'+! 6+$#! )2! %2/5,(0! )*')! 2/&1!
%'(#,2012%1)$! /6%&$,! S;AF! 42+,),R$T! .$($! %26/)$#! '/#! /2)! ($#! -&22#! %$&&! /6%&$,!
S#+=$#!42+,),R$T7!L$($'5)$(U!.$!($5$(!)2!)*$!)2)'&!/60-$(!25!EIF"!42+,),R$!/6%&$,!,/!
,+2&')$#! $0-(12/,%! *$'()+! '+! )2)'&! R$/)(,%&$! %'(#,2012%1)$+! /60-$(! SG^B/T! '/#!
FLLj! 42+,),R$! /6%&$,! '+! 4(2&,5$('),/9! R$/)(,%&$! %'(#,2012%1)$+! /60-$(! SF^B/T7!
J'04&$+!.$($! ,/,),'&&1!4($4'($#!-1!0,%(2#,++$%),/9!'/#! ($02R,/9! )*$!*$'()+! 5(20!
$0-(12+U!'+!#$)',&$#!,/!+$%),2/!O7k7P7!!
















2.9.2.3 Counting Total and Mitotic Cardiomyocyte numbers  





.'+! '++$++$#! -1! N&'/#DI&)0'/! 0$)*2#! 52(! %204'(,/9! 4',($#! 0$'+6($0$/)+! S+$$!
J)'),+),%!+$%),2/!O7PVT7!
2.9.3 Histopathology: Haematoxyl in & Eosin 




OV\! D! P[[\! ,/! 5,R$! +)$4+T! '/#! $0-$##$#! ,/! 4'('55,/! ,/! '! )('/+R$(+$! 2(! +'9,))'&!
2(,$/)'),2/7! J$(,'&! Vu0! +$%),2/+! ,/%&6#,/9! )*$! *$'()! '/#! +20$! 25! 64! '/#!
#2./+)($'0! ),++6$!.$($! %6)! 2/!'!0,%(2)20$!'/#! +)',/$#!.,)*!Lr@U! '%%2(#,/9! )2!






Figure 2.8 – Isolated zebrafish embryonic heart ventricle to assess cardiomyocyte number. 
Confocal imaging of a microdissected cmlc2:EGFP zebrafish heart ventricle at 72 hpf, stained 
with DAPI (blue). This dye labels all ventricular cells, however only DAPI positive nuclei 
overlapping GFP (green) signal were counting as cardiomyocyte nuclei. Cardiomyocytes were 
counted using ImageJ software and were counted by marking DAPI and GFP positive cells with 
a tag while moving progressively through the z-stack of images, thus ensuring individual nuclei 











2)*$(! +)(6%)6($+! S%1)24&'+0U! %2&&'9$/! '/#! 06+%&$! 5,-$(+T! +)',/$#! .,)*! $2+,/! '/#!
)*$($52($!%2&26($#!($#7!J$%),2/+!.$($!2-+$(R$#!6/#$(!%20426/#!0,%(2+%24$!+$)),/9!
O[`! 2(! Y[`! 2-Q$%),R$! '/#! ,0'9$+!.$($! %'4)6($#! -1! '!0,%(2+%24$! &,/3$#! +)'/#'(#!
%2&26(!%'0$('7!
I!:6'&,)'),R$!'/'&1+,+!25!)14,%'&!%1)202(4*2&29,%'&!'&)$('),2/+!25!'424)2),%!%$&&+!S%$&&!





2.10 Apoptotis assessment 
2.10.1 Whole-mount Terminal dUTP Nick End-
Labeling (TUNEL) assay 
G*$! Gb8@?! 0$)*2#! ,+! 6+$#! )2! '++'1! )*$! $/#2/6%&$'+$! %&$'R'9$! 4(2#6%)+! -1!
$/Z10'),%'&&1!$/#D&'-$&,/9!)*$!E8I!+)('/#!-($'3+!SH($++$&!'/#!;(2+%6()*U!PKKYw!")2!
'/#! >)+63,U! PKKkT7! I424)2),%! %$&&! #$')*! ,/! .*2&$D026/)! Z$-('5,+*! .'+! #$)$%)$#!
'%%2(#,/9!)2!'!02#,5,%'),2/!25!)*$!I424G'9!(*2#'0,/$!"/!J,)6!I424)2+,+!E$)$%),2/!
3,)!SB*$0,%2/U!BIU!bJIT!4(2)2%2&7!@0-(12+!.$($!5,X$#!2R$(/,9*)!,/!FAI!Y\!')!Y~B7!
@0-(12+!.$($!.'+*$#! ,/! FNJ! '/#! )*$! 4$(,%'(#,'&! +'%!.'+! 24$/$#! '/#! )*$! *$'()!
$X42+$#! )2! *$&4! 4$/$)('),2/! 25! %*$0,%'&+! '/#! '/),-2#,$+! .,)*,/! )*$! *$'()7! G*$/U!
$0-(12+!.$($!4$(0$'-,&,Z$#!.,)*!4(2)$,/'+$!H!SP[u9W0&T!52&&2.$#!-1!).2!56()*$(!
.'+*$+! ,/!FNJ7! !G*$1!.$($! )*$/! 5,X$#!'9',/! ,/!FAI!Y\U! )*$/! 4&'%$#! ,/! 4($%*,&&$#!
$)*'/2&f'%$),%! '%,#! SOfPT! ')! DO[~BU! .'+*$#! j! ),0$+! ,/! FNJDG.$$/! [7P\! -$52($!








Figure 2.9 – Apoptosis assays in the zebrafish. Two methods were 
used to assess apoptosis in the whole-mount embryo. Image A 
shows Terminal dUTP Nick End-Labeling (TUNEL) staining in a Wik 
(wild type) zebrafish embryo 72hpf, counterstained with DAPI. Red 
spots represent TUNEL positive nuclei labelling apoptotic bodies. 
Image B shows Acridine Orange (AO) vital dye assay in the zebrafish 
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2.10.2 Acr idine orange  
>/$!25!)*$!02+)!%2002/&1!6+$#!)$%*/,:6$+!)2!'++$++!'424)2+,+!6),&,Z$+!)*$!R,)'&!#1$!
I%(,#,/$!>('/9$!SI>T!SJ,90'DI&#(,%*!?)#7U!E2(+$)U!bHTU!'!/6%&$,%!'%,#!,/)$(%'&'),/9!
#1$! )*')! $0,)+! 9($$/! 5&62($+%$/%$! .*$/! -26/#! )2! #+E8I! '/#! +$&$%),R$&1! +)',/+!
'424)2),%!(')*$(!)*'/!/$%(2),%!%$&&+!SI-('0+U!PKKjw!A6(6)'/,U!PKK]TU!5,96($!O7K!N7!I>!
+)2%3! +2&6),2/! ,+!4($4'($#!')!P09W0&!,/!0,&&,c!.')$(!'/#!+)2($#!')! DO[BU!'/#! &,9*)!
4(2)$%)$#7! E$%*2(,2/')$#! $0-(12+! .$($! ,/%6-')$#! ,/! I>! O7Vu9W0&! ,/! $0-(12!
0$#,60! 52(! j[! 0,/+! 52&&2.$#! -1! j! ),0$+! .'+*$+! 25! P[! 0,/+! $'%*! .,)*! $0-(12!
0$#,607! G(,%',/$! O[u<! .'+! '##$#! )2! )*$! 0$#,60! )2! '/$+)*$),Z$! $0-(12+U!
'%%2(#,/9! )2! +$%),2/! O7Y7! @0-(12+! .$($! 026/)$#! 2/! '! %*'0-$($#! 9&'++! +&,#$!
SL'.3+&$1U!J6++$XU!bHT!,/!'!#(24!25!$0-(12!0$#,60!'/#!+$'&$#!.,)*!%2R$(+&,4!S+$$!
+$%),2/!O7V7PT7!J&,#$+!.$($!.('44$#!,/!'&60,/,60!52,&!)2!4($R$/)!-&$'%*,/97!!
A&62($+%$/)! 2(! %2/52%'&! 0,%(2+%24$! S;AF! 5,&)$(! +$)f! $X%,)'),2/! Y_jU! $0,++,2/! VO[T!
.$($!6+$#!)2!2-+$(R$!9($$/!5&62($+%$/%$!25!I>!,/!)*$!.*2&$!$0-(12!'/#!)*$!*$'()w!
$'%*! 9(264! ,/%&6#$+! Ü! P[! $0-(12+! 52(! $'%*! $X4$(,0$/)U! I>! &'-$&$#! 46/%)'!.$($!
%26/)$#!'+!'424)2),%!-2#,$+!S5,96($!O7K!NT7!
2.11 Protein analysis  





E$12&3$#! $0-(12+! .$($! )('/+5$(($#! ,/)2! 5($+*U! %22&$#! FNJ! +2&6),2/! '/#! (,/+$#!
).,%$7!I)!)*,+!42,/)U!$0-(12+!%'/!-$!4(2%$++$#!-$52($!&2'#,/9!2/!'!9$&!2(!5(2Z$/!,/!






2.11.2 Samples Prote in Extract ion 
J'04&$+! ,/! '! P7V0?! $44$/#2(5! )6-$! .$($! 0,%(2569$#! 52(! PDO! 0,/6)$+! '/#!
+64$(/')'/)! .'+! ($02R$#7! I-26)! P[[DPV[! u?! ="FI! ?1+,+! N655$(! S<,&&,42($U! <IU!
bJITU! 4($R,26+&1! #,&6)$#! ,/! #$,2/,Z$#! .')$(! 5(20! '! +)2%3! P[`U! .$($! '##$#! '/#!
*2029$/,Z$#!.,)*!'!0,%(2569$!4$+)&$!52(!j[!+!'/#!)*$/!+2/,%')$#!52(!j[!+!')!VDk!ueU!
6/),&!$0-(12!+'04&$!,+!/2!&2/9$(!R,+,-&$7!J'04&$+!.$($!3$4)!,/!,%$!52(!j[!0,/+U!)*$/!
.$($! -(,$5&1! R2()$X$#! '/#! )*$/! 0,%(2569$#! PDO! 0,/+! ')! 56&&! +4$$#! SPjU[[[! (40T7!
J64$(/')'/)! .'+! %2&&$%)$#! '/#! )*$/! 4&'%$#! ,/! '! /$.! P7V0?! )6-$! '/#! 4$&&$)! .'+!
#,+%'(#$#7!J'04&$+!.$($!+)2($#!')!DO[~B7!
2.11.3 Bradford Protein Assay 
G*$! 4(2)$,/! %2/%$/)('),2/+! 25! Z$-('5,+*! $0-(12+! *2029$/')$+! .$($! #$)$(0,/$#!
%2&2(,0$)(,%'&&1!6+,/9!'!N,2D='#!4(2)$,/!'++'1!3,)!SN,2D='#U!L$0$&!L$04+)$'#U!bHT!
'/#! )*$! N('#52(#!0$)*2#!25! #$)$%),2/! SN('#52(#U! PK_]T7!F(2)$,/! %2/%$/)('),2/!.'+!





+)'/#'(#+! SV! u&! $'%*T7! G*$! #,&6),2/+! 25! 6/3/2./! 4(2)$,/+! .$($! 4($4'($#! 2/! )*$!
-'+,+!25!'/!,/,),'&!'++$++0$/)!25!)*$!%2&26(!%*'/9$!642/!0,X,/9!)*$!4(2)$,/!'/#!)*$!
#,&6)$#! #1$7! G*$! '++'1! .'+! 4$(52(0$#! ')! =G7! G*$! 4&')$! .'+! +*'3$/! )2! 0,X! '/#!
'&&2.$#! )2! +)'/#! 52(! PV! 0,/+7! b^! '-+2(-'/%$! .'+! 0$'+6($#! SVKV! /0T! 2/! '!
b^WR,+,-&$! +4$%)(24*2)20$)$(! SJ*,0'#Z6U! <,&)2/! H$1/$+U! bHT! '/#! 4(2)$,/!
%2/%$/)('),2/+!25!+'04&$+!.$($!%'&%6&')$#!S$X4($++$#!'+!09W0&T!5(20!)*$!+)'/#'(#!
%6(R$U!'&&2.,/9!52(!)*$!#,&6),2/!5'%)2(7!!
2.11.4 Preparat ion of gel samples 








2.11.5 Gel electrophoresis  
J'04&$+!.$($!+$4'(')$#!-1!$&$%)(24*2($+,+!2/!'!86FI;@t!82R$Xt!YDPO\!N,+DG(,+!
;$&!P7[!00!)*,%3! S?,5$!G$%*/2&29,$+!?)#U!F',+&$1U!bHT7!G*$!9$&U! +)2($#!')!Y~BU!.'+!
5,))$#!.,)*! 9$&! )'/3! SN,2D='#! ?'-2(')2(,$+U! L$(%6&$+U! BIU! bJIT! '/#! ,00$(+$#! ,/!
86FI;@t!<>FJ! JEJ! =6//,/9! N655$(! O[`! S?,5$! G$%*/2&29,$+! ?)#U! F',+&$1U! bHTU!
4($R,26+&1! #,&6)$#! ,/! #$,2/,+$#!.')$(7! G*$! 9$&! %20-!.'+! ($02R$#! '/#! )*$!.$&&+!
.$($! 5&6+*$#!26)! )*2(269*&1!.,)*!-655$(7!G*$!.$&&+!.$($! &2'#$#!.,)*! )*$!+'04&$+!
-1! 6+,/9! 9$&! &2'#$(! ),4+! S@44$/#2(5U! bHT7! I! Vu&! 25! 82R$Xt! J*'(4! F($D+)',/$#!
F(2)$,/! J)'/#'(#! S?,5$! G$%*/2&29,$+! ?)#U! F',+&$1U!bHT!.'+! '&+2! &2'#$#! ,/! )*$! ).2!
26)$(!.$&&+!)2!,#$/),51!)*$!02&$%6&'(!.$,9*)!25!-'/#+7!;$&+!.$($!(6/!')!'!R2&)'9$!P[[!
^!52(!j[!0,/+!'/#!)*$/!')!PV[!^!52(!'/2)*$(!][!0,/+7!!
2.11.6 Gel transfer  
;$&+! .$($! )('/+5$(($#! )2! /,)(2%$&&6&2+$! 0$0-('/$+! F(2)('/! SJ,90'DI&#(,%*! ?)#7U!
E2(+$)U!bHT!6+,/9!)*$!@&$%)(24*2($),%!G('/+5$(!B$&&!SN,2('#!?'-2(')2(,$+U!L$(%6&$+U!
BIU!bJIT7!I!9$&!+'/#.,%*!.'+!4($4'($#!.,)*,/!)*$!%'++$))$!%2/+,+),/9!25!5,-$(!4'#U!
-&2)),/9! 4'4$(! S-2)*! 5(20! N,2D='#! ?'-2(')2(,$+U! L$(%6&$+U! BIU! bJITU! 9$&U!
/,)(2%$&&6&2+$!0$0-('/$U!5,&)$(!4'4$(!'/#!5,-$(!4'#7!G*$!9$&!+'/#.,%*!%'++$))$!.'+!
4&'%$#! .,)*,/! )*$! )('/+5$(! 02#6&$! '/#! )'/3U! .*,%*! .'+! )*$/! 5,&&$#! .,)*! G2.-,/!
)('/+5$(!-655$(!SG="J![7[OV!<U!;&1%,/$![7PKO!<U!4L!k7]!Ç![7PT7!G*$!)('/+5$(!.'+!(6/!')!









2.11.7 Immunoblott ing  
I5)$(! )('/+5$(U! /,)(2%$&&6&2+$! 0$0-('/$! .'+! -&2%3$#! .,)*! O[! 0&! 25! V\! #(,$#!
+3,00$#! 0,&3! S<'(R$&! F($0,$(! N('/#+! ?)#7U! ?,/%2&/+*,($U! bHT! ,/! GNJ! G.$$/!
SO[0<! G(,+DB&! á[7O!<! G(,+DB&U! 4L! _7]àU! Pj_0<! J2#,60!B*&2(,#$U! [7P\! G.$$/! O[!
áF2&12X1$)*1&$/$+2(-,)'/!02/2&'6(')$U!NELU!F22&$U!bHàT!2/!'!4&')52(0!+*'3$(!52(!P!
*26(!')!=G7!G*$/!)*$!0$0-('/$!.'+!.'+*$#!j!),0$+!SV!0,/+!$'%*T!.,)*!FNJDG.$$/!
[UP\! '/#! )*$/! ,/%6-')$#! ,/! 4(,0'(1! '/),-2#1! ')! '! %2/%$/)('),2/! '%%2(#,/9! )2!
'/),-2#1!0'/65'%)6($(! S6+6'&&1! PfV[[! D! PfP[[[T! ,/! N2R,/$! J$(60!I&-60,/! SJ,90'D
I&#(,%*!?)#7U!E2(+$)U!bHT!j\!2R$(/,9*)!')!Y~B7!G*$!0$0-('/$!.'+!.'+*$#!j!),0$+!
,//! FNJDG.$$/![UP\!4(,2(! )2! ,/%6-'),2/!.,)*!'! +$%2/#'(1!'/),-2#1U! &,/3$#! )2! )*$!
*2(+$! ('#,+*! 4$(2X1#'+$U! ')! '! %2/%$/)('),2/!25! PfP[[[[! ,/! #(,$#! +3,00$#!0,&3!V\!
52(! P! *26(7!I! 5,/'&! +$(,$+! 25!.'+*$+!.'+! 4$(52(0$#! '+! '-2R$U! -$52($! )*$! -&2)!.'+!
#$R$&24$#7!!
2.11.8 Chemiluminescent detect ion 
8,)(2%$&&6&2+$! 0$0-('/$! .'+! $X42+$#! 52(! P! 0,/! )2! )*$! @/*'/%$#!
B*$0,&60,/$+%$/%$! +2&6),2/! S@B?w! I0$(+*'0U! bHT! 52&&2.,/9! )*$!0'/65'%)6($(d+!
,/+)(6%),2/+7! @X%$++! @B?! +6-+)(')$! 5(20! )*$!0$0-('/$!.'+! ($02R$#! -1! )26%*,/9!
)*$!$#9$!25!)*$!0$0-('/$!)2!'!4,$%$!25!),++6$!4'4$(7!G*$/!)*$!0$0-('/$!.'+!4&'%$#!
#2./!2/!'!5,&0!&'1$(U!4($R,26+&1!#,+42+$#!,/+,#$!'!5,&0!%'++$))$7!G*$!-6--&$+!.$($!
%'($56&&1! ($02R$#! 5(20! )*$! 0$0-('/$! )*')! .'+! )*$/! %2R$($#! .,)*! '/2)*$(! 5,&0!
&'1$(U! 5,X$#!2/!)*$!%'++$))$!.,)*! )'4$!'/#!$X42+$#!)2!'!4*2)29('4*,%! 5,&0!SN,2<'X!
`I=!A,&0!H2#'3U!J,90'DI&#(,%*!?)#7U!E2(+$)U!bHT! 52(!'/!'#$:6')$!$X42+6($! ),0$7!
G*$! 5,&0! .'+! #$R$&24$#! '/#! ,006/2($'%),R,)1! S-'/#! #$/+,)1T! .'+! :6'/),5,$#! -1!





2.12 Gene expression analys is 
2.12.1 RNA extract ion from whole zebraf ish 
embryos 
=8I!$X)('%),2/!'/#!($R$(+$!)('/+%(,4),2/!.$($!4$(52(0$#!-1!6+,/9!c,'9$/!=8$'+1!
0,/,! 3,)! Sc,'9$/U! e$+)! J6++$XU! bHT7! @0-(12+! .$($! 4&'%$#! ,/! '/! $44$/#2(5! )6-$!
P7V0?U! $6)*'/,+$#!.,)*! )(,%',/$!2R$(#2+$! S+$$! +$%),2/!O7YT! '/#! +)2($#! ,/!=8I&')$(!
S?,5$! G$%*/2&29,$+! ?)#U! F',+&$1U! bHT! 2(U! 52(! ,00$#,')$! =8I! $X)('%),2/U! 4&'%$#!
#,($%)&1! ,/! -655$(! =?G! ][[u?7! @'%*! $44$/#2(5! )6-$! .'+! '##$#! .,)*! ).2! +0'&&!
0$)'&&,%!-$'#U!4($R,26+&1!'6)2%&'R$#!'/#!.,4$#!.,)*!=8'+$!M'4!S?,5$!G$%*/2&29,$+!
?)#U! F',+&$1U! bHT7! @55,%,$/)! #,+(64),2/! '/#! *2029$/,Z'),2/! .'+! 4$(52(0$#! -1!




$:6'&! R2&60$! 25! _[\! $)*'/2&U! 0,X$#! '/#! 4&'%$#! ,/! )*$! =8$'+1! +4,/! %2&60/!
+6-Q$%)$#!)2!%$/)(,569'),2/!SPOU[[[9U!j[!+U!Y°BT7!G*$!$&6')$!.'+!#,+%'(#$#7!
E8'+$! )($')0$/)! +)$4! 52&&2.$#! )2! $&,0,/')$! 9$/20,%! E8I! %2/)'0,/'),2/7! I5)$(!
.'+*! .,)*! N655$(! =eP! SjV[u&T! '/#! %$/)(,569'),2/! 52(! PV! +U! P[! u&! E8'+$! "! +)2%3!
+2&6),2/U! 4($R,26+&1! #,&6)$#! ,/! _[!u&! N655$(! =EEU!.$($! '##$#! )2! )*$! +4,/! %2&60/!
'/#! ,/%6-')$#! PV! 0,/+! ')! =G7! G*$! %2&60/! .'+! )*$/! .'+*$#! .,)*! N655$(! =eP!
S_[[u&T! '/#!N655$(!=F@! SV[[!u?T7! "/! $'%*! %'+$U! )*$! $&6')$!.'+!#,+%'(#$#! 52&&2.,/9!
%$/)(,569'),2/! SPOU[[[9U! PV! +U! YâBT7! N655$(! =F@! SV[[u&T! .'+! '##$#! )2! .'+*! )*$!
0$0-('/$U!52&&2.$#!-1!'!56()*$(!%$/)(,569'),2/!+)$4!SPOU[[[9U!O!0,/+U!YâBT7!G*$!+4,/!









2.12.2 RNA extraction from zebrafish embryonic 
hearts 
A2(! $'%*! +'04&$U! j[[DV[[! *$'()+! .$($! $X)('%)$#! -1! <$%*'/,%'&D'9,)'),2/! 0$)*2#!
SJ$%),2/! O7k7OT! 5(20! $0-(12+! 4($R,26+&1! 4($4'($#! '+! ,/! J$%),2/! O7PP7P7! =8I! .'+!
,+2&')$#!'+!#$+%(,-$#!,/!J$%),2/!O7PO7P7!
2.12.3 Assessment of tota l RNA quantif ication and 
purity 
=8I!.'+! :6'/),5,$#! 6+,/9! '!8'/2#(24! J4$%)(24*2)20$)$(! SG*$(02! A,+*$(U!e$+)!
J6++$XU! bHT! ,/! P! u&! 25! =8I! +'04&$7! B2/%$/)('),2/! .'+! #$)$(0,/$#! -1! )*$!
'-+2(-'/%$! ')! O][/0!.'R$&$/9)*! SIO][TU! '/#! )*$! 46(,)1! '++$++$#! -1! )*$! ('),2! 25!
=8IWE8I!SIO][WIOk[TU!.*,%*!.'+!#$$0$#!'%%$4)'-&$!,5!-$).$$/!P7K!'/#!O7PU!'/#!
O][WOj[!S+20$!%2/)'0,/'/)+U!$797!4*$/2&U!'-+2(-!')!Oj[/0T!>!O7O7!!
2.12.4 Assessment of total RNA quality 
c6'&,)1!25!=8I!.'+!'++$++$#!-1!$&$%)(24*2($+,+!2/!'9'(2+$!S?2/Z'U!N$(3+*,($U!bHT!
9$&! SP\! .WR! ,/! [7VX! GN@T7! J'04&$+! SOu&T! .$($! 4($4'($#! -1! '##,/9! &2'#,/9! #1$!






2.12.5 Reverse transcr ipt ion 
=8I! .'+! ($R$(+$! )('/+%(,-$#! ,/! %E8I! -1! 6+,/9! *,9*! %'4'%,)1! %E8I! ($R$(+$!
)('/+%(,4),2/!3,)!SI44&,$#!N,2+1+)$0+U!e'((,/9)2/U!bHT7!
A2(! $'%*! +'04&$U! '! R2&60$! %2/)',/,/9! O! u9! 25! =8I! .'+! 4,4$))$#! ,/! '! [7O0?!
0,%(2569$U!'##$#!.,)*!/6%&$'+$!5($$!.')$(!64!)2!P[!u&!'/#!)*$/!'/2)*$(!P[!u&!25!O!!





/$9'),R$! %2/)(2&+! .$($! 4($4'($#! '+! '-2R$U! 2/$! .,)*! .')$(! ,/+)$'#! 25! =8I! )2!
,#$/),51! '/1! =8I! %2/)'0,/'),2/! ,/! ($'9$/)+U! )*$! +$%2/#! .,)*26)! )*$! ($R$(+$!
)('/+%(,4)'+$!$/Z10$!,/!2(#$(! )2!#$)$%)! )*$!4($+$/%$!25!%2/)'0,/'),2/!-1!9$/20,%!
E8I7!J'04&$+!.$($!,/%6-')$#!SOV°BU!P[!0,/w!j_°BU!PO[0,/w!kV°BU!V!0,/w!Y°BU!#T!,/!
'! FB=!0'%*,/$U! -$52($! -$,/9! %*,&&$#! )2! Y°B7! G*$! ($+6&)'/)! %E8I!.'+! +)2($#! ')! D
O[°B7!
2.12.6 Quantitative Real Time PCR (Q-PCR) 
2.12.6.1 Introduction 
=$'&D),0$!2(!:6'/),)'),R$! FB=! ScDFB=T! 4$(0,)+! :6'/),5,%'),2/!25! +)'(),/9!'026/)+!
25!E8I!'/#!%E8I!)$04&')$+!'/#!,+!-'+$#!2/!)*$!#$)$%),2/!25!5&62($+%$/)!($42()$(!
02&$%6&$7!G*$!5&62($+%$/%$!'(,+$/!5(20!)*$+$!02&$%6&$+!,+!02/,)2($#!)*(269*26)!)*$!
cDFB=! 4(2%$++! '/#! ,/%($'+$+! '+! FB=! 4(2#6%)! '%%606&')$+! .,)*! $'%*! %1%&$! 25!




4(,0$(+! '($! /$$#$#U! '-,&,)1! )2! )$+)! 06&),4&$! 9$/$+! :6,%3&1! .,)*26)! #$+,9/,/9!
06&),4&$!4(2-$+U! &2.$(! ,/,),'&!%2+)! S4(2-$+!%2+)!02($TU!'/#!)*$!'-,&,)1! )2!4$(52(0!'!
0$&)D%6(R$!'/'&1+,+!)2!%*$%3!)*$!+4$%,5,%,)1!25!)*$!'04&,5,%'),2/!($'%),2/7!
B204'($#! )2! )*$! JCN=! ;($$/! 0$)*2#U! )*$! 4(2-$! -'+$#! cDFB=! 2/&1! #$)$%)+! )*$!
#$+,($#!FB=!4(2#6%)! ($+6&),/9! ,/! ,/)(,/+,%'&&1! ,/%($'+$#! +4$%,5,%,)1! '/#! +$/+,),R,)17!
I&)*269*! 5&62($+%$/)!4(2-$+!'($!:6,)$!$X4$/+,R$U! )*$1!255$(!+20$!'#R'/)'9$+!2R$(!
E8ID-,/#,/9! #1$+7! >/$! ,+! )*$,(! +4$%,5,%,)1! 52(! )*$! )'(9$)! +$:6$/%$U! )*$($52($! /2/!
+4$%,5,%!4(2#6%)+!'($!/2)!0$'+6($#7!A2(! )*,+!($'+2/U! )*,+!'++'1!#2!/2)! ,/%&6#$!0$&)!
%6(R$+!'/'&1+,+7!L1#(2&1+,+!4(2-$D-'+$#!'++'1!,+!)*$!0$)*2#!'#24)$#!,/!26(!&'-!'/#!
.'+!4$(52(0$#!-1!<+!H')*(1/!e,&+2/7!







'! +)'/#'(#! %6(R$7! I! 922#! +)'/#'(#! %6(R$! *'+! '! +&24$! %&2+$! )2! Dj7jU! &2.! $((2(U!
$55,%,$/%1! P7_! l! O7P7! A2(! +)'/#'(#! %6(R$U! .,)*! K! #')'! 42,/)+U! '/! '&,:62)! 25! /$')!
S6/#,&6)$#T!%E8I!5(20!'&&!+'04&$+!.'+!0,X$#U!'/#!)*$/!#,&6)$#!,/!)*$!4(242(),2/+!
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25! FB=! '04&,5,%'),2/U! .*,%*! %2/+,+)$#! 25! #$/')6('),2/! SKVâBU! P[! +$%TU! '//$'&,/9!
S][âBU!j[!+$%T!'/#!$&2/9'),2/!S_OâBU!P!+$%T7!b42/!%204&$),2/!25!)*$!FB=!4(29('00$U!
+'04&$+!.$($!%22&$#!SY[âBU!j[!+$%T7!A2(!'&&! )*$! +'04&$+U!'04&,5,%'),2/! %6(R$+!.$($!
4&2))$#! S1! 'X,+! 5&62($+%$/%$U! X! 'X,+! %1%&$! /60-$(T7! G(,4&,%')$+! .$($! #$$0$#!
'%%$4)'-&$! ,5! )*$! +)'/#'(#! #$R,'),2/! 25! %(2++,/9! 42,/)! SB4T! x! [7V! %1%&$+7! =$&'),R$!
:6'/),)'),2/!.'+!%'&%6&')$#!6+,/9!)*$!#$&)'!BG!0$)*2#!6+,/9!?,9*)!B1%&$(!+25).'($7!!
2.12.6.3 Normalisation of Q-PCR data 
G2!$/'-&$!:6'/),)'),2/!25!9$/$!$X4($++,2/!'%%2(#,/9!)2!)*$!'026/)!25!%E8I!&2'#$#U!
)*$! #')'! 2-)',/$#! 5(20! )*$! cDFB=! .$($! /2(0'&,+$#! '%%2(#,/9! )2! *26+$3$$4,/9!
9$/$+7! G*$+$! '($! 9$/$('&&1! %2/+),)6),R$! 9$/$+! .*,%*! &$R$&+! 25! $X4($++,2/! '($!
($&'),R$&1!%2/+)'/)!,/!4*1+,2&29,%'&!%2/#,),2/+!S;($$($#.$-2"U!O[P[T7!!
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Figure 2.10 – Gene expression pattern of the Ef1! and 18S housekeeping genes during normal 
development in the zebrafish embryo. The Ef1! mRNA level, assessed (A) at 24, 48, 72, 96 and 120 
hpf in the whole embryos and (B) at 48, 96, 120 hpf in isolated hearts and adult heart and was found 
to be stable. Ef1! was used to normalize mRNA level of genes of interest in time-course analysis. 18S 
mRNA level was also assessed (C) in the whole embryos and was found to be stable. Data were 
compared by one-way ANOVA, followed by Bonferroni’s multiple comparison test. Each time-course 
was studied in 1 clutch of eggs, at least 10 embryos from the clutch were used to generate each time 
point. The data represents an average from studies in 3 clutches of eggs.  
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Figure 2.11 – Expression pattern of Ef1! and "-actin housekeeping genes in the zebrafish embryo 
following treatments. A. Ef1! was affected by flavopiridol during development at 48, 72 and 96 hpf, 
therefore it was not used to normalise Q-PCR data following flavopiridol and morpholino treatments. B-
C. "-actin was not affected in the same conditions, therefore it was used to normalize mRNA level in 
experiments requiring exposure to flavopiridol (B), measured at  48, 72 and 96 hpf, or injection of 
morpholino (C), measured at  48 and 96 hpf. Data were compared by two-way ANOVA followed by 
Bonferroni’s multiple comparison test. Each time-course was studied in 1 clutch of eggs, at least 10 
embryos from the clutch were used to generate each time point. The data represents an average from 
studies in 3 clutches of eggs. ns= non significant difference  


















2.13 Genetic knockdown by Morpholino 
ol igonucleotides 
2.13.1. Preparation of microin jection needles 
G*$!0,%(24,4$))$+!6+$#! ,/! )*$!0,%(2,/Q$%),2/!.$($! 5($+*&1!4($4'($#!'/#!9$/$(')$#!
-1!46&&,/9!9&'++!%'4,&&'(,$+! S;BP[[GADP[U!L'(R'(#!I44'(')6+!?)#7U!H$/)U!bHT!.,)*!
)*$! 0,%(24,4$))$! 46&&$(! SFBDP[! 46&&$(U! 8I="JL";@U! B'0-(,#9$U! bHTU! +$$!
0'/65'%)6($(d+! ,/+)(6%),2/!52(! 56&&!#$)',&+7!F6&&,/9!'/#! %&,4! )$04$(')6($!.$($!]K~B!
'/#!_V7K~B!($+4$%),R$&17!N$52($!,/Q$%),2/U!)*$!/$$#&$!),4+!.$($!%'($56&&1!4($4'($#!)2!
*'R$!'!5,/'&!),4!25!'-26)!P[!µ0!-1!6+,/9!'!+6(9,%'&!52(%$4!SE602/)!VT7!!
2.13.2 Morpholino design 
I/),+$/+$! 02(4*2&,/2! S<>T! )2! 3/2%3#2./! BEHK! '/#! ?I=F_! $X4($++,2/! ,/! )*$!
Z$-('5,+*!.$($!#$+,9/$#!.,)*! )*$!*$&4!25! )*$! %204'/1!;$/$!G22&+! S>($92/U!bJIw!
...79$/$D)22&+7%20T!)*')!+1/)*$),+$#!'&&!<>+7!!
"! +6-0,))$#! )2! ;$/$! G22&+! )*$! )'(9$)! 0=8I! +$:6$/%$+! 52(! #$+,9/! '/#! )*$1!
+699$+)$#! )*$! -$+)! 24),2/7! G*$! )('/+&'),2/! -&2%3,/9! <>! .'+! #$+,9/$#! )2! -$!
%204&$0$/)'(1! )2! +$:6$/%$!-$).$$/! )*$!Vã! %'4! '/#!'-26)! OV!-'+$+! jã! 25! )*$!Ib;!
)('/+&'),2/! +)'()! +,)$! '/#! ,/*,-,)+! 4(29($++,2/! 25! )*$! ,/,),'),2/! %204&$X7! G*$! +4&,%$!
-&2%3,/9! <>! )'(9$)$#! )2! )*$! +4&,%$! Q6/%),2/! -$).$$/! $X2/! O! '/#! ,/)(2/! O! 25! )*$!
)'(9$)!4($D=8IU!52(!-2)*!BEHK!'/#!?I=F_7!I!0,+0')%*!%2/)(2&+!52(!)*$!+4&,%$!+,)$!
02(4*2&,/2! .'+! #$+,9/$#! )2! +$(R$! '+! /$9'),R$! %2/)(2&+7! I&&! <>+! .$($! jdD$/#!
&'-$&$#! .,)*! ?,++'0,/$! 5&62(2%*(20$+U! '! ($#! 5&62($+%$/)! )'9! )2! 02/,)2(! )*$!
#,+)(,-6),2/! 25! <>+! .,)*,/! )*$! $0-(12+7! G*$! <>+! +$:6$/%$+! 6+$#! '($! &,+)$#! ,/!
%*'4)$(!Y7!!!









2.13.4 Morpholino in jection procedure 
2.13.4.1 Calibration 
G*$!0,%(2,/Q$%),2/! 25! 5$(),&,+$#! $99+!.'+! 4$(52(0$#! ')! )*$! PDY! %$&&! #$R$&240$/)'&!
+)'9$+!6+,/9!'!8'(,+*,9$!"<j[[!<,%(2,/Q$%)2(U!)2!0'X,0,+$!02(4*2&,/2!4$/$)('),2/!
,/! '&&! %$&&+7! 82(0'&&1U! '/! '44(2X,0')$! ,/Q$%),2/! 4($++6($! 25! O[! 4+,! '/#! '! 46&+$!
#6('),2/!25! j!0,&&,+$%2/#!.$($! 6+$#7!E6(,/9! )*$! %'&,-('),2/!4(2%$#6($U! '! -2&6+!25!
02(4*2&,/2!25!'-26)![7P!00!25!#,'0$)$(!.'+! ,/Q$%)$#!6/#$(! )*$!?$,%'!A&62!<MP]!
5&62($+%$/%$!0,%(2+%24$!S?$,%'!<,%(2+1+)$0+!?)#7U!N6%3U!bHT!,/)2!'!#(24!25!0,/$('&!
2,&!4($R,26+&1!4&'%$#!2/!'! P!00!9('),%6&$!.,)*! [7[P!00!#,R,+,2/+! S5,96($!O7PO!IT7!
G*$!'026/)!25!02(4*2&,/2!.'+!%'&%6&')$#!-1!)*$!('#,6+!25!)*$!-2&6+!'/#!'%%2(#,/9!
)2! )*$! 52(06&'! 25! '! +4*$($! SYWj! •! $! •! (jT7! G*$! +'0$! -2&6+U! /2(0'&&1! [7V! /?U! .'+!
,/Q$%)$#!,/)2!)*$!12&3!+'%!25!$'%*!$997!G*$!+'0$!0,%(24,4$))$!6+$#!52(!)*$!%'&,-('),2/!
'/#!4($++6($!+$)),/9+!.'+!'&+2!6+$#!)2! ,/Q$%)!$99+7!@'%*!/$.!0,%(24,4$))$U!$,)*$(!'!
-(23$/! ($4&'%$0$/)! /$$#&$! 2(! %*'/9$! 25! ,/Q$%),2/! +2&6),2/U! 6+$#! ($:6,($#!
%'&,-('),2/7!
2.13.4.2 Morpholino injection 
I!/2(0'&!9&'++!+&,#$!.'+!4&'%$#! ,/!'!K[!00!F$)(,!#,+*U!$99+!.$($!4&'%$#! ,/)2! )*$!
#,+*!'/#U!-1! 6+,/9!'!4&'+),%! ),4U!42+,),2/$#!2/!'! +&,#$! +,#$7! "/!2(#$(! )2! ($#6%$! $99!
02R$0$/)+U! $X%$++! 25! .')$(! .'+! '-+2(-$#! 2/! '! 4,$%$! 25! ),++6$7! <2(4*2&,/2! .'+!









Figure 2.12 - Morpholino injection procedure. A. The amount of morpholino to 
inject into the eggs was previously calibrated on a slide graticule of 1mm, with 
0.01mm divisions. B. Eggs at 1-4 cell stage were carefully placed in a 90mm 
Petri dish, at the flank of a glass slide and a bolus of 5 nL was injected in each 
egg. C. Successful injection was assessed under fluorescence microscope by 
the morpholino red tag lissamine. D-E Images of embryos captured at 24 and 
48 hpf show the large diffusion of the morpholino in the whole body. 
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2.13.5 Defining the whole-embryo and cardiac 
phenotype 
A2&&2.,/9! 5&'R24,(,#2&! $X42+6($U! $0-(12! +)'/#'(#! -2#1! &$/9)*!.'+!0$'+6($#! '+!
)*$!#,+)'/%$!5(20!)*$!+/26)!)2!)*$!%'6#'&!4$#6/%&$7!G*,+!R'&6$!,+!#,+),/%)!5(20!)2)'&!
-2#1!&$/9)*U!.*,%*!,+!0$'+6($#!)2!)*$!#,+)'&!),4!25!)*$!%'6#'&!5,/7!G2)'&!-2#1!&$/9)*!
%'/! -$! %2/526/#$#! -1! 5,/! #'0'9$!'/#! ,+!/2)! ($%200$/#$#! 52(! +)'9,/9!46(42+$+7!
J)'/#'(#!-2#1!&$/9)*!%2(($&')$+!.$&&!.,)*!'&&!2)*$(!0$'+6($+!25!+,Z$!SF'(,%*1$#.$-2"U!
O[[KT!'/#!,+!'++2%,')$#!.,)*!2R$('&&!$0-(12/,%!#$R$&240$/)7!!
A2&&2.,/9! 02(4*2&,/2! ,/Q$%),2/U! Z$-('5,+*! $0-(12+! +6(R,R'&! '/#! 4*$/2)14$!.$($!
$X'0,/$#!$R$(1!#'1!5(20!P!64!)2!V!#'1+!42+)!5$(),&,+'),2/!S#45T7!e*2&$!$0-(12!'/#!
%'(#,'%! 4*$/2)14$! .$($! #$+%(,-$#! 2/! )*$! -'+,+! 25! 02(4*2&29,%! '/#! 56/%),2/'&!
%*'('%)$(,+),%+7! @0-(12! 4*$/2)14$!.'+! -'+$#! 2/! )*$! 52&&2.,/9! 4'('0$)$(+f! L$'#!
+,Z$! S82(0'&U! +0'&&$(T! '/#! N2#1! 'X,+! S/2(0'&! S[DV\TU! %6(R$#! SVDV[\TU! %6(R$#!
SÉV[\TT7!B'(#,'%!4*$/2)14$!.'+!-'+$#!2/!)*$!52&&2.,/9!4'('0$)$(+f!G',&!-&22#!5&2.!
S/2(0'&U!($#6%$#U!'-+$/)TU!F$(,%'(#,'&!2$#$0'!S/2(0'&U!0,&#U!+$(,26+TU!L$'()!+*'4$!
S/2(0'&U! )6-6&'(U!+)(,/9TU!L$'()!(')$U! S/2(0'&! SPY[DO[[-40TU! &2.! S][DPY[-40TU!R$(1!
&2.!S[D][-40TT7!I&&!)*$+$!$X4$(,0$/)+!.$($!4$(52(0$#!-1!01+$&5!'/#!$'%*!$0-(12!
.'+! '(-,)('(,&1! ,/%&6#$#! ,/! 2/$! 25! )*$! '-2R$! %')$92(,$+7! I)! &$'+)! Y! #,55$($/)!







2.14 Preparation and optimization of 
pharmacological agents 
2.14.1 Aphid icolin 
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Figure 2.13 - Optimization of the pharmacological agent Aphidicolin. A. Curve of embryo 
survival following exposure to aphidicolin. Zebrafish embryos at 24hpf were exposed to 
several concentration of aphidicolin (here are shown 30 and 75 !M in DMSO 1 or 2%), 
surviving embryos were counted every 24 hours until 120hpf. B. Curve of cell proliferation, 
measured as BrdU positive nuclei, in zebrafish embryos following exposure to different dose 
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Figure 2.14 – Cell cycle inhibition by Aphidicolin 30 µM in the zebrafish embryo. Four 
representative fluorescent images of the zebrafish embryo tail exposed to Aphidicolin 30 µM, the 
concentration adopted in this thesis, at 6 and 24 after exposure to the drug, showing BrdU 
positive nuclei (red puncta). In order to select a suitable concentration of drug to use, embryos 
were previously exposed to different doses of Aphidicolin, in the range 15-150µM, and DMSO to 
favour the drug penetration. At 6, 24 and 48 hours after exposure to the drug, BrdU 
immunostaining was performed in the whole embryo to assess the effect of the Aphidicolin on 
cell proliferation.  
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2.14.2 Flavopiridol  
A&'R24,(,#2&!,+!'!-(2'#!+4$%,5,%,)1!BEH!,/*,-,)2(!.,)*!'!#,+),/%)!4($5$($/%$!52(!BEHK!
SB*'2$ #.$ -2"U! O[[[T7! A&'R24,(,#2&! SJ,90'T! .'+! #,&6)$#! ,/! E<J>! SJ,90'TU! %'((,$(!
+2&R$/)U!')!'!+)2%3!%2/%$/)('),2/!25!P0<7!N',!$)!'&7U!SN',$#.$-2"U!O[P[T!($42()$#!)*')!')!'!
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(2&$!25!BEHK!$,)*$(!#6(,/9!/2(0'&!#$R$&240$/)!2(!52&&2.,/9!&'+$(!,/Q6(1!')!_O*457!
G*$($52($U!'!#2+$!('/9,/9!+)6#1!.'+!4$(52(0$#!6+,/9!5&'R24,(,#2&!')!%2/%$/)('),2/+!
25!Pu<!D!Vu<!2R$(!OYDYk!*26(+! ,/!$0-(12+!')!YkDPO[!*45! S/|j[!4$(!9(264TU! 5,96($!
O7PV7!"/,),'&&1U!$X42+6($!)2!)*$!A&'R24,(,#2&!.'+!+)'()$#!Q6+)!'5)$(!5$(),&,Z'),2/!-6)!)*,+!
%'6+$#!)*$!#$')*!25!P[[\!$0-(12+!OY!*457!G*$($52($U!)*$!+)'(),/9!42,/)!.'+!+$)!')!OY!
*457! @0-(12! +6(R,R'&U! 9(2++! -2#1! '/#! 9(2++! %'(#,'%! 02(4*2&291! .$($! $R'&6')$#!
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Figure 2.15 - Curve of embryo survival following exposure to flavopiridol. For the 
optimization of this pharmacological agent, different groups of zebrafish embryos were 
continuously exposed, from 24hpf up to 120 hpf, to a dose of flavopiridol 1, 3 or 5!M. 




















2.15 Data handling and Statist ical Analysis 
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Figure 2.16 – Bland-Altman analysis for Total Ventricle Cardiomyocyte number (TVCn). This 
statistics was employed to assess Intra-observer (A) and Inter-observer (B) variation in counting 
cardiomyocyte with ImageJ. The difference between measures are plotted against the mean for 
the two analysis. The dotted line represents the 95% limits of agreement. TVCn was assessed 


































Figure 2.17 - Bland-Altman analysis for Ejection Fraction. This statistics was applied to 
assess Intra-observer (A) and Inter-observer (B) variation in the measurement of area with 
ImageJ. The difference between the measures are plotted against the mean for the two tests. 
The dotted line represents the 95% limits of agreement. Ejection Fraction was assessed 
twice in the same embryos (number of embryos=12).  
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Figure 3.1 - cmlc2:EGFP zebrafish embryonic heart 72hpf. This still images of the same 
heart are part of two videos captured with a colour camera under white light (A-B) and 
fluorescence light (C-D). Images on the right and left side show the ventricle in end-diastole 














3.2 Materials and Methods  
3.2.1 Zebrafish lines 
M$-('5,+*! )('/+9$/,%! %0&%Of@;AF! $0-(12+! .$($! 6+$#! 52(! '&&! $X4$(,0$/)+U! 6/&$++!
+)')$#7!!
3.2.2 Ventr icle structure and cardiomyocyte 
proliferat ion 
B*'/9$+! ,/! R$/)(,%6&'(! +)(6%)6($! '/#! )2)'&! R$/)(,%6&'(! %'(#,2012%1)$! /60-$(!
SG^B/T!.$($!'++$++$#!#6(,/9!#$R$&240$/)'&!+)'9$+!Yk!S*')%*,/9!4$(,2#TU!_OU!K]!'/#!
PO[! *45! S$'(&1! &'(R'T! -1! 0,%(2#,++$%),/9! $0-(12/,%! *$'()+! SJ$%),2/! O7k7PTU! +)',/$#!
.,)*!EIF"!SJ$%),2/!O7K7OT!'/#!'/'&1+,/9!6/#$(!%2/52%'&!0,%(2+%24$!SJ$%),2/!O7K7O7jT7!!
G*$!.*2&$!R$/)(,%&$!+)(6%)6($!.'+!'/'&1+$#!-1!2-+$(R,/9!)*$!;AF!+,9/'&7!"/!2(#$(!)2!
R,+6'&,Z$! '&+2! )*$! +*'4$! 25! ,/D+,)6! +,/9&$! %'(#,2012%1)$+U! *$'()+! '/'&1+$#! 52(!
R$/)(,%&$!+)(6%)6($!.$($!'##,),2/'&&1!+)',/$#!.,)*!'/!'/),-2#1!'9',/+)!E<D;=IJFU!
'! +'(%2&$00'&! ,/)$9(,/U! %'&&$#! Z/DV! S026+$w! 4(2#6%$#! -1! E$R$&240$/)'&! J)6#,$+!
L1-(,#20'!N'/3T!#,&6)$#!PfO[[!,/!FNJ!%2/)',/,/9!NJI!V\7!!
3.2.3 Cardiovascular function 
<$)*2#+! 52(! %'(#,2R'+%6&'(! 56/%),2/! 0$'+6($0$/)+! *'R$! -$$/! #$)',&$#! ,/! +$%),2/!
O7]w! )*$+$! ,/%&6#$#! $Q$%),2/! 5('%),2/! S@AT! '/#! R$/)(,%6&'(! #,'+)2&,%! '($'! S^EIT!
S+$%),2/! O7]7OTU! *$'()! (')$! SL=T! S+$%),2/! O7]7jTU! '/#! %'(#,/'&! R$,/! -&22#! R$&2%,)1!
SB^N^T!S+$%),2/!O7]7YT7!
3.2.4 Gene expression analysis 
cDFB=! )$%*/,:6$U! #$+%(,-$#! ,/! #$)',&+! ,/! +$%),2/! O7POU! .'+! 6+$#! )2! '++$++! )*$!
$X4($++,2/!4'))$(/! ,/! )*$!4$(,2#!OY! )2!PO[!*45! 52(!'!('/9$!25!9$/$+! ,/R2&R$#! ,/! )*$!
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02/)*! '9$T! *$'()+7! "! $X'0,/$#! '! /60-$(! 25! *26+$3$$4,/9! 9$/$+! )2! '++$++!.*,%*!
($0',/$#!02+)! +)'-&$! #6(,/9! )*$! $'(&1! 4$(,2#! 25! #$R$&240$/)! 5(20! OY! )2! PO[! *45!
S+$$! 5,96($+!O7K! ,/!B*'4)$(!O! 52(!'&&!*26+$3$$4,/9!9$/$+T7! "!+6-+$:6$/)&1!%*2+$! )*$!
*26+$3$$4,/9!9$/$!@AP!!)2!$/'-&$!:6'/),)'),2/!25!9$/$!$X4($++,2/!'%%2(#,/9!)2!)*$!
'026/)!25!%E8I!&2'#$#7!!
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3.2.6 Statist ics 
























Table 3.1 – Details of primers for real-time PCR for use with Roche Universal Probe Library 
(UPL). These include gene name with Pubmed accession number, Forward (F) and Reverse (R) 

















































3.3.1 Cardiac Growth 
3.3.1.1 Ventricle Morphology 
I/'&1+,+! 25! R$/)(,%&$! +)(6%)6($! +*2.$#! '! 4(29($++,R$! ,/%($'+$! ,/! )*$! R$/)(,%&$!
)('-$%6&'),2/! S5,96($!j7OT7!I)! Yk! *45U!/2! )('-$%6&'(! 52(0'),2/!.'+!2-+$(R$#7!G*$+$!
+)'()$#!)2!52(0!')!_O!*45!'/#!,/%($'+$!')!K]!*45U!.*,&$!')!PO[!*45!'!#('0'),%!,/%($'+$!
25! )('-$%6&'$! .'+! 2-+$(R$#! S5,96($! j7OT7! I&)*269*! )*$! '/),DE<D;=IJF! +)',/,/9!
'&&2.$#!R,+6'&,Z'),2/!25!'!9(2++!%'(#,2012%1)$!+*'4$U!'!4($%,+$!0$'+6($0$/)!25!,/D
+,)6!+,/9&$!%'(#,2012%1)$!'($'!.'+!/2)!($&,'-&$7!
3.3.1.2 Ventricle Cardiomyocyte Number 
G2)'&! R$/)(,%&$! %'(#,2012%1)$! /60-$(+! SG^B/T! #6(,/9! /2(0'&! Z$-('5,+*! *$'()!
#$R$&240$/)! ,/%($'+$#! +,9/,5,%'/)&1! -1! j[\! -$).$$/! Yk! '/#! _O! *45! S4x[7[VTU! O[\!
-$).$$/!_O!'/#!K]!*45! S4x[7[PT!'/#!V[\!-$).$$/!K]!'/#!PO[!*45! S4x[7[[PT! S5,96($!
j7jT7!
3.3.1.3 Ventricle Diastolic Area 
G*$! +,Z$! 25! )*$! R$/)(,%&$! SR$/)(,%6&'(! #,'+)2&,%! '($'U! ^EIT! S5,96($! j7Y! I! r! NT!
,/%($'+$#!-$).$$/!Yk! )2! _O!*45! '/#! ,/%($'+$#! +,9/,5,%'/)&1!-$).$$/!Yk!'/#!K]!*45!
S4x[7[VTU!.*,&$!,)!+&,9*)&1!#$%($'+$#!-$).$$/!K]!'/#!PO[!*457!
3.3.2 Cardiac Function 
3.3.2.1 Ejection Fraction 
B'(#,'%! 56/%),2/U! '++$++$#! '+! R$/)(,%&$! 5('%),2/'&! '($'! %*'/9$U! *'#! R'&6$+! ,/! )*$!




















Figure 3.2 - Zebrafish embryo ventricle morphology. Confocal images of cmlc2:EGFP zebrafish embryo 
heart ventricle at different developmental stage (expressed in hour post-fertilization (hpf)), stained with 
anti-DM-GRASP (sarcolemmal integrin) in red, and counterstained with DAPI. Each time-point reports 
images of the same heart, of the ventricle surface (left side) and inside the ventricle (right side). Red 

















Figure 3.3 - Total ventricle cardiomyocyte number during normal development. A- images of cmlc2:GFP zebrafish embryo heart ventricles at 
several developmental age. At each time point, image captured under confocal microscopy show DAPI stained nuclei (upper panel), counted as 
single cardiomyocytes and the GFP background (lower panel). B- Diagram, showing the increase of total ventricle cardiomyocyte numbers over 
the time period, with an acceleration in the period 96-120 hpf. One-way ANOVA was employed to compare means, followed by Bonferroni’s 
multiple comparison test. N=4 experiments were performed. In each experiment, embryo hearts derived from the same clutch of eggs.  
 







































































Figure 3.4 - Ventricle diastolic area (VDA) and Ejection fraction (EF) analysis in the zebrafish embryo. Analysis were repeated every day in the 
same embryos (tg(cmlc2:EGFP) line) from 48-120 hpf. A. Still images extracted from a video captured under fluorescence microscopy 
representing the cmlc2:GFP zebrafish embryo heart at the different developmental age. B. Diagrams showing variation in Ventricle diastolic area 
during the development, with a significant increase between 48 and 96 hpf. C. Diagrams showing variation in Ejection fraction during the 
development; there was no significant change between the different time point. A repeated measures one-way ANOVA was employed followed 
































































































3.3.2.2 Heart Rate 
$%&'(!'&(%! )*+,%-!&!)./0*(!&1-!2'+0'%))/3%! /14'%&)%! 5'+6!78! (+!9#:!*25! ;5/0<'%!=>?!
@A>!B1%C,&D!@EBF@!(%)(!-/-!1+(!)*+,!)/01/5/4&1(!-/55%'%14%)!&6+10!6%&1)!&(!(*%!
-/55%'%1(!(/6%!2+/1()>!!
3.3.2.3 Posterior Cardinal Vein Blood Velocity 
G'D(*'+4D(%! 3%.+4/(DH! 6%&)<'%-! /1! (*%! I%J'&5/)*! %6J'D+! 2+)(%'/+'! 4&'-/1&.! 3%/1H!
/14'%&)%-!)/01/5/4&1(.D!J%(,%%1!78!&1-!"K!*25!;2L:>:?A!&1-!78!&1-!9#:!*25! ;2L:>:9A!
,*/.%! /(! )*+,%-! 3%'D! )/6/.&'! 3&.<%)! &(! M#! &1-! "K! *25>! N*%1! /(! )./0*(.D! /14'%&)%-!
J%(,%%1!"K!&1-!9#:!*25!;5/0<'%!=>?!OA>!!
3.3.3 Gene expression 
N'&1)4'/2(/+1! 5&4(+')! )*+,1!*%'%! ;5/0<'%! =>K! &1-! =>MA!,%'%! 4*+)%1! +1! (*%! J&)/)! +5!
(*%/'!/62+'(&14%!/1!4&'-/&4!-%3%.+26%1(!+5!F%'(%J'&(%)!;O'&1-H!#::=A>!!




3.3.3.1 Gene expression in the developing Whole Embryo  













Figure 3.5 - Heart rate and cardinal vein blood velocity analysis in the zebrafish embryo. 
Analysis were repeated at 24 h interval in the same embryos (tg(cmlc2:EGFP) line) from 48-120 
hpf. A. Heart rate slightly increased over the time period but with no statistical significant 
changes. B. Cardinal vein blood velocity also increased over the time period, with statistical 
significant changes between 48 hpf and other time point. A repeated measures one-way 
ANOVA was employed to compare means, followed by Bonferroni’s multiple comparison test. 









































































Figure 3.6 – Expression of cardiac relevant transcription factors genes in the zebrafish whole embryo. 
mRNA levels were assessed by Q-PCR during normal development from 24 to 120 hpf and were 
normalised against the housekeeping gene Ef1!. One-way ANOVA was employed followed by 
Bonferroni’s multiple comparison test. N=3 experiments. Each time-course was studied in 1 clutch of 
eggs, at least 10 embryos from the clutch were used to generate each time point. The data represents 
an average from studies in 3 clutches of eggs. 
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Figure 3.7 - Expression of cardiac relevant transcription factors genes in the zebrafish embryonic heart. 
mRNA levels were assessed by Q-PCR during normal development at 48, 96 and 120 hpf, and in the 
adult (6 month age) heart. mRNA was normalised against the housekeeping gene Ef1!. One-way ANOVA 
was employed followed by Bonferroni’s multiple comparison test. N=3 experiments. Each time-course was 
studied in 1 clutch of eggs, at least 10 embryos from the clutch were used to generate each time point. 



























































































































































































3.4.  Discussion 
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*&)! J%%1! '%2+'(%-! (+! <1-%'./%! )+6%! 4&)%)! +5! 4+10%1/(&.! *%&'(! -/)%&)%! ;g*+<! "#! $%&H!
#:9#A>! T@N@7! &1-! K!,%'%! 5+<1-! (+! *&3%! &! )/6/.&'! 2&((%'1! +5! %R2'%))/+1! &1-! (*/)!
&0'%%)!,/(*!&!2'%3/+<)!'%2+'(!)*+,/10!(*&(!T@N@7!&1-!K!4+C%R2'%))!-<'/10!%&'.D!
6<'/1%! -%3%.+26%1(H! ,/(*! J+(*! %R2'%))%-! /1! (*%! 2%'/4&'-/&.! 6%)+-%'6H! (*%!
%6J'D+1/4! *%&'(! (<J%H! &1-! (*%! -%3%.+2/10! %1-+-%'6! ;U+''/)%D! "#! $%&H! 9""KA! &1-!
4+1(/1<%!(+!J%!%R2'%))%-! /1! (*%!&-<.(!*%&'(! ;U+''/)%D! "#!$%&H!9""MA>! Q1-%%-H!T@N@7!
&1-! T@N@K! 2'+(%/1)! 2*D)/4&..D! /1(%'&4(! &1-! )D1%'0/)(/4&..D! &4(/3&(%! (&'0%(! 0%1%!
('&1)4'/2(/+1H! /1! 2&'(/4<.&'! (*%! \GVC9! 1<4.%&'! 2'+(%/1CJ/1-/10! )/(%! /1! (*%! 4&'-/&4C
)2%4/5/4!4N1\!('&1)4'/2(/+1&.!%1*&14%'!;\*&''+1!"#!$%&H!#::9A>! Q1!4+1('&)(H!T@N@?!/)!
%R2'%))%-! /1! &! (%62+'&..D! &1-! )2&(/&..D! '%)('/4(%-! 2&((%'1! -<'/10! %&'.D! %6J'D+1/4!




)*+,%-! )/6/.&'! %R2'%))/+1! 2&((%'1! &)! 5+'! T@N@K! /1! (*%! I%J'&5/)*!,*+.%! %6J'D+>!









)%3%'&.!+'0&1/)6)! /14.<-/10!6+<)%H!4*/4PH! 5'+0!&1-!I%J'&5/)*!%6J'D+)! ;U4V&--%1!
"#! $%&H! #::?A>!U&66&./&1)! '%(&/1! (,+! 0%1%)H! $&1-! 9! &1-! $&1-! #H! ,*/.%! I%J'&5/)*!
0%1+6%!&22%&')!(+!%14+-%!+1.D!$&1-!#!;h%.+1!"#!$%&H!#:::A>!g%J'&5/)*!6<(&1()!,/(*!
$&1-! P1+4PC+<(! ;$&1-)! +55A! )*+,! &!6+'%! )%3%'%! 2*%1+(D2%! 4+62&'%-! (+!$&1-#!
P1+4P+<(! 6/4%! &1-! /(! *&)! J%%1! )2%4<.&(%-! (*&(! (*/)! /)! -<%! (+! (*%! .&4P! +5!
4+62%1)&(+'D! &4(/3/(D! +5! &! )%4+1-! $&1-! 0%1%! /1! (*%! I%J'&5/)*! ;U4V&--%1! "#! $%&H!
#::?A>!
!!
Q1! 4+14.<)/+1H! /1! (*/)! 4*&2(%'! Q! *&3%! 4*&'&4(%'/I%-! )%3%'&.! &)2%4()! +5! (*%!
-%3%.+26%1(&.! -D1&6/4)!+5! (*%!I%J'&5/)*! *%&'(! 3%1('/4.%! /1! (*%! 2%'/+-!78C9#:!*25H!
/14.<-/10! 4*&10%)! /1! 4&'-/&4! 5<14(/+1H! 3%1('/4.%! -/&)(+./4! &'%&! &1-! (*%! 2&((%'1! +5!
4*&10%!4&'-/+6D+4D(%)!1<6J%'!&1-!0%1%!%R2'%))/+1>!N*%!5<14(/+1&.!4*&'&4(%'/)(/4)!
+5!(*%!*%&'(!&22%&'!(+!J%!%)(&J./)*%-!%&'.D!/1!-%3%.+26%1(H!&(!&'+<1-!78!*+<')H!,/(*!
1+! )/01/5/4&1(! /14'%&)%! /1! %`%4(/+1! 5'&4(/+1!&5(%'! (*/)! (/6%>!$+,%3%'H! 0/3%1! (*&(! (*%!
*%&'(!'&(%!/14'%&)%)!2'+0'%))/3%.D!+3%'!(*/)!(/6%!2%'/+-!(*%!+3%'&..!4&'-/&4!+<(2<(!/)!
./P%.D! (+! '/)%! /1! +'-%'! (+! )<22.D! (*%! 0'+,/10! 1%%-)! +5! (*%! %6J'D+>! Q! &.)+!
-%6+1)('&(%-! (*&(! (*%! 2%'/+-! +5! 0'%&(%)(! /14'%&)%! /1! )/I%! +5! (*%! *%&'(! -+%)! 1+(!
4+''%)2+1-! (+! (*%! 2%'/+-! +5! 0'%&(%)(! /14'%&)%! /1! 4&'-/+6D+4D(%! 1<6J%'>! N*/)!
&22&'%1(! 2&'&-+R!6&D! J%! %R2.&/1%-! JD! 4*&10%)! /1! J.++-! 3+.<6%! &1-! ('&1)6<'&.!
5+'4%)! ,/(*/1! (*%! 3%1('/4.%! 4&3/(D! 4&<)/10! -/.&(&(/+1! 2'%4%-/10!! &! 2%'/+-! +5! ,&..!
(*/4P%1/10! &1-!! &44%.%'&(%-! 4&'-/+6D+4D(%! 2'+./5%'&(/+1! &(! &'+<1-! -&D! ?>! N*/)!
*/0*./0*()!(*%!5&4(!(*&(!(*%!*%&'(i)!%&'.D!)('<4(<'%!&1-!5<14(/+1!/13+.3%)!&1!/1(%'2.&D!
J%(,%%1! 4&'-/&4! 0'+,(*! &1-! +'0&1/I&(/+1! 4+6J/1%-! ,/(*! 2*D)/4&.! 5+'4%)! ,*/4*!
4*&10%!&(!-/55%'%1(!'&(%)!-<'/10!(*/)!'&2/-!%&'.D!-%3%.+26%1(&.!2*&)%>!Q!&.)+!)*+,%-!
&! 4+62.%R! &1-! 4*&10/10! 2&((%'1! +5! %R2'%))/+1! +5! )%3%'&.! 0'+,(*! 5&4(+')! -<'/10!
-%3%.+26%1(!/1!,*+.%!%6J'D+)!&1-!/1!/)+.&(%-!%6J'D+1/4!*%&'()>!N*%)%!4*&10%)!&'%!





































\D4./1C-%2%1-%1(! Y/1&)%! ;\^YA"! &4()! JD! 2*+)2*+'D.&(/10! (*%! 4&'J+RDC(%'6/1&.!
-+6&/1!+5!WE@!2+.D6%'&)%!QQ!&1-!2'+6+(%!4%..<.&'!WE@!)D1(*%)/)>!Q(!/)!(*%'%5+'%!+5!
5<1-&6%1(&.! /62+'(&14%! (+! 4%..<.&'! 5<14(/+1! &1-! 5+'! (*/)! '%&)+1! /(! /)! &.)+! 4.+)%.D!
'%0<.&(%->! Q1! 0%1%'&.H! /(! /)! &4(/3%! ,*%1! 4+6J/1%-!,/(*! \D4./1)! ;XCNGVJ! 4+62.%RA!
&1-! /(! /)! '%2'%))%-!,*%1! +(*%'!6+.%4<.%)H! '&"&! M]YCWE@H!$GZQU! &1-!b@WXMH! `+/1!
(*%! XCNGVJ! 4+62.%RH! 5+'6/10! &1! /1*/J/(+'D! 4+62.%R>! N*/)! 2&(*,&D! /)! ./P%.D! (+! J%!
/62+'(&1(!/1!-'/3/10!(*%!/14'%&)%-!WE@!&1-!2'+(%/1!)D1(*%)/)!(D2/4&..D!+J)%'3%-!/1!
4&'-/&4! *D2%'('+2*D! &1-! *&)! J%%1! 2'+2+)%-! &)! &! P%D! '%0<.&(+'! +5! (*%! 4&'-/&4!
*D2%'('+2*/4!'%)2+1)%!;]&1+!"#!$%&H!#::#A>!$+,%3%'H!(*%!(*%'&2%<(/4!2+(%1(/&.!+5!(*/)!
2&(*,&D!&'/)%)! 1+(!+1.D! 5'+6! (*%!2+))/J.%! /1*/J/(/+1!+5! &1!&J1+'6&.!*D2%'('+2*/4!
'%)2+1)%! J<(! &! 5<'(*%'! +3%'.++P%-! 2+))/J/./(D! /14.<-%)! (*%! &4(/3&(/+1! +5! \^Y"! (+!
/1-<4%! &! 5&3+'&J.%! *D2%'('+2*/4! '%)2+1)%! )<4*! &)! (*&(! )%%1! /1! 2'%01&14D! +'!,/(*!
%R%'4/)%! ('&/1/10>!N*%'%5+'%H! /1! (*/)!4*&2(%'! Q!)%(!+<(! (+!4+62&'%!&1-! 4+1('&)(!J+(*!
/1*/J/(/+1! &1-! &4(/3&(/+1! +5! \^Y"! /1! +'-%'! (+! &))%))! (*%! 2+(%1(/&.! (*%'&2%<(/4!




X&'(!9!-%)4'/J%)! (*%!'+.%!+5!\^Y"!&1-!(*%!%55%4()!+5! /()! /1*/J/(/+1!-<'/10!I%J'&5/)*!
-%3%.+26%1(H!,/(*!%62*&)/)!+1!4&'-/&4!-%3%.+26%1(!&1-!5<14(/+1>!!















Effects of CDK9 inhibition on global 






















4.1.1 Introduction  
\D4./1C-%2%1-%1(! P/1&)%! ;\^YA"! /)! &! '%0<.&(+'D! 6+.%4<.%! &4(/3&(%-! 5+..+,/10!
J/1-/10! (+! \D4./1! N! ;X%10! "#! $%&H! 9""8AH! 5+'6/10! &! *%(%'+-/6%'! (*&(! /)! (*%! 4+'%!
%.%6%1(! +5! (*%! 2+)/(/3%C&4(/10! ('&1)4'/2(/+1! %.+10&(/+1! 5&4(+'! ;XCNGVJA! ;g*+<! &1-!
h/PH! #::KA>! Q(! /)! <J/c</(+<).D! %R2'%))%-! /1!6&1D! +'0&1)! ;]*+'%! "#! $%&H! #::?AH!,*/4*!
'%.&(/3%! &J<1-&14%! -%2%1-)! +1! (*%! -%3%.+26%1(&.! )(&0%! &1-! 4%..! 4+66/(6%1(!
;Y+*+<(%PH! #::"A>! Q(! *&)! J%%1! /13+.3%-! /1! )%3%'&.! 6%4*&1/)6)! -<'/10! (*%!
-%3%.+26%1(>! Q1! 0'+,(*! 4+1('+.! +5! 2'/6+'-/&.! 0%'6! 4%..)! ;XT\)A! ;BP&6<'&! "#! $%&H!




@! (/))<%C)2%4/5/4! '+.%! 5+'! \^Y"! /1! -%3%.+26%1(! *&)! J%%1! /1-/4&(%-! /1! I%J'&5/)*!
%6J'D+)H!,*%'%! .+))!+5!\^Y"!)%.%4(/3%.D!J.+4P)!-%5/1/(/3%!*%6&(+2+/%)/)! ;U%/%'! "#!
$%&H!#::KA>!!!
Q1! &-<.(*++-H! \^Y"! &1-! XCNGVJ! &4(/3/(D! &22%&')! (+! J%! */0*.D! %R2'%))%-! /1!
(%'6/1&..D!-/55%'%1(/&(%-! 4%..)! &1-! (/))<%)! ;O&0%..&! "#! $%&H! 9""8AH! (*/)! )<00%)()! &! '+.%!
5+'!(*/)!P/1&)%!/1!)2%4/&./I%-!4%..<.&'!5<14(/+1)>!!
O%4&<)%!+5!/()!4%1('&.!'+.%!/1!(*%!('&1)4'/2(/+1!'%0<.&(/+1!;T&''/0&!&1-!T'&1&H!#::7AH!
\^Y"!*&)!J%%1! /62./4&(%-! /1!2&(*+.+0/4! 4%..<.&'!2'+4%))%)!;Y'D)(+5! "#!$%&H!#:9:A>! Q1!
4&'-/&4! '%6+-%./10H! (*/)! *D2+(*%)/)! /)! )<22+'(%-! JD! 2'%3/+<)! '%)%&'4*! /1-/4&(/10!
(*&(!\^Y"!%R2'%))/+1!/)!<2C'%0<.&(%-!&1-!&4(/3/(D!%1*&14%-!/1!4&'-/&4!*D2%'('+2*D!
;]&1+! "#! $%&H! #::#A! &1-! 4*'+1/4! &4(/3&(/+1! +5! \^Y"! 2'%-/)2+)%)! (+! *%&'(! 5&/.<'%! /1!
&-<.(! 6+<)%! 6D+4&'-/<6>! @! 6&`+'! 5/1-/10! /1! -/55%'%1(! 6+-%.)! ,&)! (*%! 5&4(! (*&(!
J+(*!*D2%'('+2*D!&1-! 1+'6&.! 4&'-/&4! -%3%.+26%1(! 4+''%)2+1-! (+!&1!%1.&'0%6%1(!
+5!(*%!4&'-/+6D+4D(%)!,/(*!/14'%&)%-!WE@!&1-!2'+(%/1!)D1(*%)/)>!
]<'2'/)/10.DH! 3%'D! 5%,! -&(&! &'%! &3&/.&J.%! +1! (*%! '+.%! +5! \^Y"! -<'/10! 4&'-/&4!
-%3%.+26%1(!;d&01%'!"#!$%&H!#::8A>!!





+'! /1! '%)2+1)%! (+! )('%))! ;^/! ](%5&1+! "#! $%&H! #:99A>! Q1! 5&4(H!^/! ](%5&1+! %(! &.>! /1-<4%-!
P1+4P-+,1! +5! %1-+0%1+<)! \^Y! /1*/J/(+')! JD! )6&..! /1(%'5%'/10! WE@! /1! 4<.(<'%-!
6+<)%! 4&'-/+6D+4D(%)H! (*%'%JD! &4(/3&(/10! +'! -/)C/1*/J/(/10! \^Y">! N*/)! ('/00%'%-!
J+(*! 1%+1&(&.! &1-! &-<.(! 4&'-/+6D+4D(%)! (+! '%C%1(%'! (*%! 4%..! 4D4.%! '%)<.(/10! /1!
2'+./5%'&(/+1!+5! 2'%3/+<).D! c</%)4%1(! 4%..)! ;^/!](%5&1+! "#! $%&H! #:99A>!$+,%3%'H! (*%)%!
,+'P%')! -/-! 1+(! /-%1(/5D!,*/4*! )2%4/5/4!\^Y!+'!\^Y)!,%'%! &4(/3&(%->! \^Y"! *&)!
&.)+! J%%1! )*+,1! (+! '%0<.&(%! 4%..C4D4.%! &1-! /)! /13+.3%-! /1! -/55%'%1(/&(/+1! +5!
4&'-/+6D+4D(%)!5'+6!6/4%!%6J'D+1/4!)(%6!4%..!;Y&/4*/!"#!$%&H!#:99A>!

























4.1.2 Materials and Methods 
4.1.2.1 Zebraf ish lines 
g%J'&5/)*! ('&1)0%1/4! 46.4#aGTVX! %6J'D+)! ,%'%! <)%-! /1! &..! %R2%'/6%1()H! <1.%))!
)(&(%->!!
4.1.2.2 Whole embryo and cardiac phenotype  
@))%))6%1(! +5!,*+.%! %6J'D+! &1-! 4&'-/&4! 2*%1+(D2%!,&)! -%)4'/J%-! /1!\*&2(%'! #H!
)%4(/+1!#>9=>?>!
4.1.2.3 Total  body length and Heart- to-body length 
ratio  







4.1.2.4 Cardiovascular funct ion 
\&'-/+3&)4<.&'! 5<14(/+1! ,&)! &))%))%-! <)/10! (%4*1/c<%)! &1-! 6%(*+-)! +<(./1%-! /1!
\*&2(%'! #H! ]%4(/+1! #>KS! (*%)%! /14.<-%-! %`%4(/+1! 5'&4(/+1! ;GVAH! *%&'(! '&(%! ;$WAH!
3%1('/4<.&'!-/&)(+./4!&'%&!;F^@AH!(+(&.!;NF\1A!&1-!2'+./5%'&(/10!;XF\1A!3%1('/4<.&'!
4&'-/+6D+4D(%!1<6J%'!&1&.D)/)>!
4.1.2.5 CDK9 Gene knockdown 
U+'2*+./1+!(%4*1+.+0D!JD!/1`%4(/+1!+5!&1(/)%1)%!+./0+1<4.%+(/-%)!;+./0+)A!,&)!<)%-!
(+! J.+4P! 6WE@! ('&1)4'/2(/+1! ;)2./4%! J.+4P/10A! +'! 6WE@! ('&1).&(/+1! ;('&1).&(/+1!






























Table 4.1.1 – CDK9 morpholino oligonucleotides sequences. 
Danio rerio cyclin-dependent kinase 9 (CDC2-related kinase) mRNA 
Pubmed Accession number NM_212591.1 
Morpholino sequences 
Splice blocking   5’-CTTTCTTCCCCATTCTTTTACGTGG-3’ (exon 3 / intron 3) 
Mismatch 5’-CTTTgTTgCCgATTgTTTTACcTGG-3’ 





J.+4P/10H! #:! kU! 5+'! \^Y"! ('&1).&(/+1! J.+4P/10A! ,&)! /1`%4(%-! /1! %00)! &(! 9C7! 4%..!
)(&0%H! (*%'%5+'%! -%./3%'/10! &J+<(! :H?! 10! &1-! :H9! 10! +./0+1<4.%+(/-%)! ,/(*! %&4*!
/1`%4(/+1! '%)2%4(/3%.D! 5+'! (*%! )2./4%! J.+4P/10! &1-! (*%! ('&1).&(/+1! J.+4P/10!
6+'2*+./1+>!
4.1.2.6 Pharmacological treatment of embryos 
V.&3+2/'/-+.! /)! &! ,%..C'%4+01/I%-! )2%4/5/4! \^Y"! /1*/J/(+'! ;\*&+! "#! $%&H! #:::A>!
g%J'&5/)*! %6J'D+)!#7*25!,%'%!2.&4%-! /1! %6J'D+!6%-/<6!4+1(&/1/10!V.&3+2/'/-+.!
=kU! ;]/06&A! 2'%3/+<).D! -/.<(%-! /1! ^U]B>! E+! ^U]B!,&)! &--%-! /1! (*%! %6J'D+!
6%-/<6>! ]+.<(/+1)! ,%'%! '%2.&4%-! &(! 78H! M#! &1-! "K*25>! N*%! 4+14%1('&(/+1! +5!
V.&3+2/'/-+.!<)%-!,&)!4*+)%1!&5(%'!&!-+)%!'&10/10!)(<-D!&(!4+14%1('&(/+1)!+5!9kU!C!
?kU>!G6J'D+!)<'3/3&.H!0'+))!J+-D!2*%1+(D2%!&1-!0'+))!4&'-/&4!6+'2*+.+0D!,%'%!
&))%))%-! 5+..+,/10! %R2+)<'%! (+! 3&'/+<)! 4+14%1('&(/+1)! +5! 5.&3+2/'/-+.! ;)%%! )%4(/+1!
#>97>#A>!N*%!5/1&.!4+14%1('&(/+1!)%.%4(%-!5+'!&..!)<J)%c<%1(!%R2%'/6%1()!,&)!=kU!&)!
(*/)!'%)<.(%-!/1!(*%!.+,%)(!-%0'%%!+5!1+1C)2%4/5/4!(+R/4/(D!(+!(*%!,*+.%!%6J'D+!,*/.%!
&.)+! '%)<.(/10! /1! &! )/01/5/4&1(! -%4'%&)%! /1! \^Y"! &4(/3/(D! 4+15/'6%-! JD! '%-<4%-!
2*+)2*+'D.&(/+1!+5!(*%!)%'/1%!#!'%)/-<%!+5!WE@!2+.D6%'&)%!QQ>!
4.1.2.7 Gene expression analysis 
[CX\W!(%4*1/c<%H!-%)4'/J%-!/1!-%(&/.)!/1!)%4(/+1!#>9#H!,&)!<)%-!(+!&))%))!(*%!6WE@!
.%3%.)>! N*%! (/6%C4+<')%! /1! (*%! 2%'/+-! #7! (+! 9#:! *25! 5+'!\^Y"!,&)! &))%))%-! /1! (*%!
,*+.%!%6J'D+!;)%4(/+1!#>9#>9A!&1-!/1!/)+.&(%-!%6J'D+1/4!*%&'()!;)%4(/+1!#>9#>#A!&1-!
&-<.(! ;K! 6+1(*! &0%A! *%&'()>! 6WE@! .%3%.)! +5! \^Y"H! b@WXMH! T@N@7H! ?! &1-! KH!
UGV#\H! NOZ?! &1-! EYZ#>?! 5+..+,/10! 5.&3+2/'/-+.! %R2+)<'%! &1-! 6+'2*+./1+!
/1`%4(/+1!,%'%!&.)+!&))%))%-!/1!(*%!,*+.%!%6J'D+!&(!78!&1-!"K!*25>!!
Q!2%'5+'6%-!&1!&))%))6%1(!+5!3&'/+<)!*+<)%P%%2/10!0%1%)!/1!(*%)%!%R2%'/6%1()>!
G59!! ,&)! 5+<1-! (+! J%! 4+1)(&1(! -<'/10! 1+'6&.! -%3%.+26%1(! &1-! ,&)! 4*+)%1! (+!
%1&J.%! c<&1(/(&(/+1! +5! \^Y"! 0%1%! %R2'%))/+1! J%(,%%1! #7C9#:! *25>! d*%'%&)! Q!





(*%'%5+'%H! <)%-! (*%! *+<)%! P%%2/10! 0%1%! lC&4(/1! (+! %1&J.%! c<&1(/(&(/+1! +5! 0%1%!
%R2'%))/+1!&44+'-/10!(+!(*%!&6+<1(!+5!4^E@!.+&-%-!5+'!J+(*!5.&3+2/'/-+.!&1-!UBC
\^Y"!('%&(%-!%6J'D+)>!!
4.1.2.8 Protein analysis  





<1./P%.D! (+! 4*&10%! /1! (*%! 3&'/+<)! %6J'D+! 0'+<2)>! Q1! &..! %R2%'/6%1()! ,/(*!
V.&3+2/'/-+.H! (*%! .+&-/10!4+1('+.!2'+(%/1!<)%-!,&)!3/(%..+0%1/1>!F/(%..+0%1/1! /)! (*%!
6+)(! &J<1-&1(! %00! D+.P! 2'+(%/1H! 2'%)%1(! &)! 5'&06%1(! +5! -/55%'%1(! )/I%! ;(*%! J&1-!
)*+,%-! /1! 5/0<'%! 7>9>8! 4+''%)2+1-! (+! (*%! 99:P^&! 5'&06%1(A! <)%-! &)! )+<'4%! +5!
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4.1.2.9 Stat istics 
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4.1.3.1 CDK9 gene expression during normal 
zebrafish development  
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4.1.3.2 Pharmacological inhib it ion of CDK9  
4.1.3.2.1 Embryo survival following exposure to flavopiridol  
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Figure 4.1.1 – Assessment of CDK9 gene expression during normal zebrafish development. This 
was assessed in whole embryos collected from 24 to 120 hpf (A) and in isolated embryonic hearts 
at 48, 96, 120 hpf and adult heart (6 months age) (B). Data were compared by one-way ANOVA 
followed by Bonferroni’s multiple comparison test. Each time-course was studied in 1 clutch of 
eggs, at least 10 embryos from the clutch were used to generate each time point. The data 





























































Figure 4.1.2 - Cumulative survival curve following exposed to flavopiridol 3µM. Embryos 
from the same clutch of eggs were continuously exposed to flavopiridol 3µM from 24 to 
120 hpf. Surviving embryos were counted at 6, 24, 48, 72, 96 hpf. Mean ± SEM, N= 4 































































Figure 4.1.3 - Effects of Flavopiridol on zebrafish embryo total body length. Panel A – Images 
showing the difference between embryos 96hpf control or exposed to the drug. This is 
graphically reported in Panel B, where embryo length was measured as the distance from the 
snout to the posterior tip of the notochord. The experiment was performed in at least 5 
embryos per group. N=3 experiments, for each experiment embryos derived from the same 
clutch of eggs. Student’s t-test was used to assess difference between the two groups of 
embryos.  
0.5mm 





Figure 4.1.4 - Effect of Flavopiridol  3µM  on the zebrafish embryonic cardiac phenotype. H&E 
sections showing the reduced size and the extensive pericardial edema in the heart exposed to 
the drug (B) compared to control (A). Heart images of in-vivo ventricle in diastole show 
pericardial edema again and a reduced ventricle area in the ventricle exposed to the drug (D) 
compared to control (C). Images were captured in embryo 96hpf. E- Graph showing the heart-
to-total body length ratio, significantly reduced in embryos exposed to the drug compared to 
control. The experiment was performed in at least 5 embryos per group. N=3 experiments, for 
each experiment embryos derived from the same clutch of eggs. PS=pericardial sac, 


























































4.1.3.2.3 Effects of flavopiridol on cardiac function  
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4.1.3.2.4. Effects of flavopiridol on cardiomyocyte proliferation  
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Figure 4.1.5 - Effect of flavopiridol on the zebrafish embryonic heart ventricle. Embryos 
from the same clutch of eggs were continuously exposed to flavopiridol 3µM from 24 to 
120 hpf. Ventricle diastolic area (A) and ejection fraction (B) were assessed in the 
same embryos, control and exposed to the drug, at 72, 96 and 120 hpf. N=3 
experiments, *=p<0.05, **=p<0.01, ***=p<0.001. Two-way ANOVA test for repeated 
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Figure 4.1.6 - Effects of flavopiridol on ventricle cardiomyocyte proliferation. Embryos from the same 
clutch of eggs were continuously exposed to flavopiridol 3µM from 24 to 120 hpf. Hearts from at 
least 5 embryos per group, control or exposed to the drug, were dissected and stained with DAPI for 
total cardiomyocyte number at 72, 96 and 120 hpf (A) or anti PHH3 for mitotic cardiomyocytes 
number analysis at 72 and 120 hpf. Representative confocal images of stained cmlc2;GFP hearts 
are shown in the panel A, the blue DAPI staining marks the nuclei while the red PHH3 positive 
nuclei mark proliferating cardiomyocytes. Mean±SEM, N=3 experiments, *=p<0.05, **=p<0.01 
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4.1.3.2.6 Effects of flavopiridol on protein expression 
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Figure 4.1.7 - Effects of Flavopiridol on the gene expression. Embryos from the same clutch of eggs were continuously exposed to flavopiridol 3µM from 24 
to 120 hpf. At 48, 72 and 96 hpf mRNA was extracted from whole embryos (at least 10 embryo per group). Level of CDK9, LARP7 and relevant gene for 
cardiac development GATA4, 5 and 6, MEF2c and TBX5 were detected by Q-PCR analysis. mRNA were normalised to the housekeeping gene ß-actin. 





































































































































































































Figure 4.1.8 - Effects of Flavopiridol on the protein expression. Embryos from the same clutch 
of eggs were continuously exposed to flavopiridol 3µM from 24 to 120 hpf. At 48, 72 and 96 
hpf protein were extracted from whole embryos and separated by gel electrophoresis followed 
by western blot (A). Membrane were blotted against Phospho-Ser2 (CTD) (B) or CDK9 (C). 
Protein level are normalised to vitellin (fragment 110KDa) to compare control and treated 
group at the same time point. N= 3 experiments, at least 5 embryo per group were used in 
each experiment, **=p<0.01, ***=p<0.001, two-way ANOVA test was used to compare means, 


































































4.1.3.3 Genetic reduction/inhibit ion of CDK9 by 
Morpholino treatment  
4.1.3.3.1 Embryo survival following MO-CDK9 injection 
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4.1.3.3.2 Effects of MO-CDK9 on CDK9 transcription and protein 
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Figure 4.1.9- Cumulative survival curve following CDK9 genetic knockdown. Zebrafish eggs 
from the same clutch were injected at 1-2 cell stage with CDK9 morpholino mismatch, 
splice or translation blocking. Surviving embryos were counted at 6, 24, 48, 72, 96 and 120 
hpf. Non-injected group represent a basic control to for the egg quality. N=4 experiments, at 






























Figure 4.1.10 – Effect of MO-CDK9 injection on the CDK9 expression. CDK9 mRNA (A) and 
protein (B) level were assessed at 48 and 96 hpf and were significantly reduced following 
injection of MO-CDK9splice blocking and MO-CDK9 translation blocking, respectively. Panel 
C shows western blot membranes with the CDK9 isoform of 55KDa more abundant than the 
smaller one (42KDa). ß-actin was used to normalize mRNA level, while tubulin was used to 
normalize protein level. N=3 experiments, at least 10 embryos per group, **=p<0.01, 
***=p<0.001, one-way ANOVA test was used to compare means, followed by Bonferroni’s 














































































4.1.3.3.3 Characterisation of the phenotype following MO-CDK9 
injection 
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Figure 4.1.11- Characterisation of the 72hpf zebrafish embryo and cardiac phenotype following CDK9 
morpholino treatment. Each diagram report on the X axis a specific trait, which phenotypic severity 
increase from left to right. On the Y axis is reported the percentage of embryos retaining that phenotype. 
The first two diagrams with body axis and head shape explain the embryo body phenotype while lower 
diagrams with tail blood flow, pericardial edema, heart shape and heart rate are related to the cardiac 










































































































Figure 4.1.12a – Zebrafish embryo control non-injected. In all morpholino experiment, a 
control group of non-injected embryo is included to take into account of the variability in 
the quality of the eggs’clutch. Indeed, each clutch is different and can present a different 
mortality and this must be taken into account in the assessment of the mortality in 
embryos injected with morpholino.  Image A shows an in-vivo zebrafish embryo 72 hpf. 
Image B shows a  H&E stained embryo section at 72 hpf, with the boxed area reported 
at higher magnification in C. Image D and E show respectively an in-vivo image of the 
zebrafish beating heart and an H&E stained heart section. Key: BA - bulbus arteriosus, 



























































Figure 4.1.12b – Effect of MO-CDK9mismatch injection in the zebrafish embryo. 
Zebrafish eggs were injected at 1-4 cell stage with this control morpholino. Image 
A and B show an overall view of embryos at 72 hpf under white and fluorescence 
light to show the successful injection by the morpholino-linked red lissamine (white 
star). One of the embryos is shown at higher magnification in image C. Image D 
shows a H&E stained embryo section, with the boxed area reported at higher 
magnification in E. Image F shows an in-vivo image of beating heart while image 
G shows a H&E stained heart section. Key: BA - bulbus arteriosus, V - ventricle, 



















Figure 4.1.12c – Effect of MO-CDK9splice blocking injection in the zebrafish 
embryo. Zebrafish eggs were injected at 1-4 cell stage. Image A and B show an 
overall view of embryos at 72 hpf under white and fluorescence light to show the 
successful injection by the morpholino-linked red lissamine (white star). One of the 
embryos is shown at higher magnification in image C. Image D shows a H&E 
stained embryo section, with the boxed area reported at higher magnification in E. 
Image F shows an in-vivo image of beating heart while image G shows a H&E 





































Figure 4.1.12d – Effect of MO-CDK9translation blocking in the zebrafish embryo. 
Images A and B show an overall view of embryos at 72 hpf under white and 
fluorescence light to show the successful injection by the morpholino-linked red 
lissamine (white star). One of the embryos is shown at higher magnification in image 














Figure 4.1.13 - Effects of CDK9 genetic knockdown on cardiac structure and function. Embryo 
eggs 1-4 cell stage from the same clutch were injected with MO-CDK9 splice blocking or MO-
CDK9 mismatch. (A) Ejection fraction, (B) Ventricle diastolic area and (C) Total ventricle 
cardiomyocyte number in the zebrafish embryonic heart were assessed at 72, 96 and 120 hpf. 
N=3 experiments, *=p<0.05, **=p<0.01, ***=p<0.001,two-way ANOVA test was used to 
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4.1.3.3.5 Effects of CDK9 MO treatment on whole embryo gene 
expression 
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4.1.3.3.6 Immunohistochemistry with CDK9 antibody  
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Figure 4.1.14 – Effects of CDK9 genetic knockdown on the gene expression. Embryo eggs 1-4 
cell stage from the same clutch were injected with MO-CDK9 splice blocking or MO-CDK9 
mismatch. At 48 and 96 hpf, mRNA was extracted from whole embryos (at least 10 embryo 
per group). Level of relevant gene for cardiac development GATA4, 5 and 6, MEF2c, TBX5 
and LARP7 were detected by Q-PCR analysis. mRNA level were normalised to the 
housekeeping gene ß-actin. N=3 experiments, *=p<0.05, two-way ANOVA test followed by 
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Figure 4.1.15 – CDK9 immunohistochemistry in a whole mount zebrafish embryo. 
Confocal images of cmlc2:GFP zebrafish embryo 72 hpf immunostained with anti-CDK9 
antibody, in red, and counterstained with DAPI. In control embryos (A), the staining 
showed a diffused presence of CDK9 in both nucleus and cytoplasm through the whole 
embryo body, here presented only in the tail. The boxed area is shown at higher 
magnification in C. While image B shows the GFP heart with anti-CDK9 staining in the 
area of the bulbus arteriosus. In the image D, embryos injected with MO-CDK9splice did 
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4.1.4 Discussion  
4.1.4.1 Role and expression of CDK9 in zebraf ish 
during normal development 
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4.1.4.2 Pharmacological modulation of CDK9: 
Impacts on g lobal and cardiac development and on 
gene expression 
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4.1.4.3 Genetic modulat ion of CDK9: impact on 
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)M5*5N'*5! S5! <'Q+1! (')! 10P)0(LQ0PM! J5)S55(! )M5! )S'! N'*IP! -(1! ]! -I! )M5*5N'*5!
Q(-J+5! )'! <'I/-*5! 10*5<)+K! S0)M! /QJ+0PM51! 1-)-R! b'S5.5*?! [-/'+0)-('! 5)! -+R!
0(10<-)51! )M-)!&8FE!S-P! /*51'I0(-()+K! +'<-)51! 0(! )M5! (Q<+5QP! JQ)! <'Q+1! -+P'! J5!
.0PQ-+0`51! 0(! )M5! <K)'/+-PI! 6[-/'+0)-('! "#! $%&?! #>>#9R! 7M5K! 0()5*/*5)51! )M50*!
'JP5*.-)0'(P!-P! PQLL5P)0(L!)M-)!&8FE!0P!-<)0.5+K!5Y/'*)51!N*'I!)M5!(Q<+5QP! )'! )M5!
<K)'/+-PI!-(1!)M-)!+5/)'IK<0(!%?!-!P/5<0N0<!0(M0J0)'*!'N!(Q<+5-*!5Y/'*)?!0(M0J0)P!)M0P!
/*'<5PPR!!





<K<+0(! 7":&8FE! M5)5*'10I5*P! )'! N'*I! )M5! 0(-<)0.5! 237H,J! <'I/+5Y! 6%+-`5W! "#! $%&?!




5IJ*K'P! 0(V5<)51!S0)M!TU3&8FEP/+0<5!J+'<W0(L?! )M5!/*5P5(<5!'N!*51! P/5<W+5P!S-P!




7M5*5! -*5! P5.5*-+! <5++3)K/5! P/5<0N0<! )*-(P<*0/)0'(! N-<)'*P! 5PP5()0-+! 1Q*0(L! )M5!
15.5+'/I5()-+!/*'<5PP5P!'N!<-*10'IK'<K)5P!64-<M0(010P!"#!$%&?!#>>$9?!-+P'!S'*W0(L!0(!
<'3'/5*-)0'(! 6e-*L! "#! $%&?! #>>$9R!g5!M-.5!-PP5PP51! )M5! 5Y/*5PP0'(!'N! P'I5!'N! )M5P5!
N-<)'*P!-(1!N'Q(1!)M-)?!'.5*-++?!)M5!5Y/*5PP0'(!'N! )M5P5!L5(5P!S-P!P+0LM)+K!*51Q<51?!
-(1! P0L(0N0<-()+K! *51Q<51! -)! EB! M/N! N'*! eO7O! B! -(1!TH,#<?! 0(! 5IJ*K'P! 0(V5<)51!
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1510<-)51!*5<*Q0)I5()!'N!237H,J!JK!0(1Q<0J+5!)*-(P<*0/)0'(!N-<)'*P!-(1!%Z8@R!!
!
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Effects of LARP7 on global and 
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-(1!4)5++5*?!#>">9R!
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`5J*-N0PM! 5IJ*K'! JK! Q)0+0P0(L! -! P)*-)5LK! 'N! ;OZ2D! L5(5)0<! W('<W1'S(! QP0(L!
I'*/M'+0('R!
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4.2.2 Methods  
4.2.2.1 Zebraf ish lines 
c5J*-N0PM! )*-(PL5(0<! <I+<#_He,2! 5IJ*K'P! S5*5! QP51! N'*! -++! 5Y/5*0I5()P?! Q(+5PP!
P)-)51R!!
4.2.2.2 Embryo survival and phenotype  
HIJ*K'!PQ*.0.-+!S-P!-PP5PP51!-)!B?!#@?!@C?!D#?!EB!-(1!"#>!M/NR!gM'+5!5IJ*K'!-(1!
<-*10-<!/M5(')K/5!S5*5!15P<*0J51!-P!P)-)51!0(!<M-/)5*!#?!P5<)0'(!#R"$RAR!
4.2.2.3 Cardiovascular  funct ion and cardiomyocyte 
analysis 
HV5<)0'(! N*-<)0'(! 6H,9?! M5-*)! *-)5! 6bZ9?! .5()*0<Q+-*! 10-P)'+0<! -(1! -)*0-+! -*5-! 6G8O?!
O8O9!-(1!)')-+!.5()*0<Q+-*!<-*10'IK'<K)5!(QIJ5*!67G&(9!S5*5!-PP5PP51R!T5)M'1P!
-*5!15P<*0J51!0(!15)-0+!0(!<M-/)5*!#?!P5<)0'(!#RB!-(1!#RER#R!
4.2.2.4 LARP7 gene knockdown 
T'*/M'+0('!-()0P5(P5!'+0L'(Q<+5')015P!S5*5!QP51!)'!0(M0J0)!;OZ2D!IZ[O!P/+0<0(L!
6TU3;OZ2DP/+0<59! '*! IZ[O! )*-(P+-)0'(! J+'<W0(L! 6TU3;OZ2D)*-(P9! 6P55! )-J+5!
@R#R"9R! O! I0PI-)<M! '+0L'(Q<+5')015! 6TU3;OZ2DI0PI9! S-P! QP51! -P! -! <'()*'+R! O!
.'+QI5!'N!>RA!(;!'N!TU3;OZ2D!6<'()-0(0(L!#>>!fT!N'*!50)M5*!TU3;OZ2DP/+0<5!'*!
TU3;OZ2D)*-(P9! S-P! 0(V5<)51! 0(! )M5! `5J*-N0PM! 5LLP! K'+W! P-<! -)! "3@! <5++! P)-L5R! O!
15)-0+51!15P<*0/)0'(!'N!)M0P!)5<M(0aQ5!0P!15P<*0J51!0(!&M-/)5*!#?!P5<)0'(!#R"$R!!
4.2.2.5 Gene expression analysis 
hQ-()0)-)0.5!2&Z!M-P!J55(!QP51!)'!5Y-I0(5!;OZ2D!5Y/*5PP0'(!0(!)M5!SM'+5!5IJ*K'!
-(1! 0(! 0P'+-)51! 5IJ*K'(0<! -(1! -1Q+)! M5-*)P! 1Q*0(L! ('*I-+! 15.5+'/I5()! -(1! )'!
15)5<)! )M5! 5Y/*5PP0'(! 'N! &8FE?! eO7O! @?! A! -(1! B?! TH,#&! -(1! 7%iA! ! N'++'S0(L!
;OZ2D! W('<W1'S(! 0(! SM'+5! 5IJ*K'PR! ]! /5*N'*I51! -(! -PP5PPI5()! 'N! .-*0'QP!
M'QP5W55/0(L! L5(5P! 0(! )M5P5! 5Y/5*0I5()PR! HN""! S-P! <M'P5(! )'! ('*I-+0P5! ;OZ2D!








4.2.2.6 Protein analysis  
2'+K-<*K+-I015! e5+! H+5<)*'/M'*5P0P! -(1! g5P)5*(! J+'))0(L! 6P55! P5<)0'(! #R""9! S5*5!
QP51! N'*! P5I0aQ-()0)-)0.5! -(-+KP0P! 'N! ;OZ2D! 6-()0J'1K! /*'1Q<51! 0(! *-JJ0)j!
OG@>C@C?! 40LI-3O+1*0<M9! 0(! SM'+5! 5IJ*K'P! 0(V5<)51! S0)M! I'*/M'+0('! -(1!
*5P/5<)0.5!<'()*'+PR! 










Table 4.2.1 – LARP7 morpholino oligonucleotides sequences. 
Danio rerio La-ribonucleoprotein domain family, member 7 (LARP7), mRNA. 
Pubmed Accession number NM_199930.1 
Morpholino sequences 
Splice blocking 5’-TCATCTCCATACTAAACCAAACTGT-3’ (exon 3 / intron 3) 
Mismatch 5’-TgATgTCCATAgTAAACgAAACTcT-3’ 





4.2.3.1 LARP7 gene expression dur ing normal 
zebrafish development   
;OZ2D! IZ[O!S-P! 15)5<)51! JK! h32&Z! 0(! )M5! SM'+5! 5IJ*K'?! -P! S5++! -P! ! 0(! )M5!
5IJ*K'(0<! -(1! -1Q+)! M5-*)P! 6B! I'()M! '+19! 6N0LQ*5! @R#R"9R! ](! )M5! SM'+5! 5IJ*K'?!
;OZ2D! 5Y/*5PP0'(! *5-<M51! )M5! /5-W! -)! @C! M/N! -(1! )M5(! P0L(0N0<-()+K! 15<*5-P51!
)'S-*1P!D#?!EB!-(1!"#>!M/NR! ](! 0P'+-)51!5IJ*K'(0<!M5-*)P?!;OZ2D!IZ[O!0(<*5-P51!
P+0LM)+K!J5)S55(!@C!-(1!EB!M/N! -(1! )M5(! P0L(0N0<-()+K! *51Q<51!-)! "#>!M/N!SM5*5! 0)!
PM'S51!)M5! +'S5P)!.-+Q5R! ](! )M5!-1Q+)!M5-*)?!;OZ2D!IZ[O!+5.5+!S-P!P0L(0N0<-()+K!
M0LM5*!<'I/-*51!)'!)M5!5IJ*K'(0<!M5-*)!-)!"#>!M/N!-(1!P0I0+-*!)'!)M'P5!'JP5*.51!-)!
5-*+05*!15.5+'/I5()-+!P)-L5P!6N0LQ*5!@R#R"9R!!
4.2.3.2 LARP7 Morpholino knockdown 
4.2.3.2.1 Embryo survival following morpholino injection 
HIJ*K'! PQ*.0.-+?! -)! "#>! M/N?! S-P! E"X?! C>X! -(1! DCX?! *5P/5<)0.5+K! 0(! )M5! L*'Q/!
0(V5<)51! S0)M! TU3;OZ2DI0PI?! TU3;OZ2DP/+0<5! -(1! TU3;OZ2D)*-(P+! 6P55!
5IJ*K'!PQ*.0.-+!<Q*.5!0(!N0LQ*5!@R#R#9R!
4.2.3.2.2 Effects of MO-LARP7 on LARP7 gene and protein levels 
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Figure 4.2.1 – Assessment of LARP7 gene expression during normal zebrafish development. This 
was assessed in whole embryos collected from 24 to 120 hpf (A) and in isolated hearts at 48, 96, 
120 hpf and adult heart (B). Data were compared by one-way ANOVA followed by Bonferroni 
multiple comparison test. Each time-course was studied in 1 clutch of eggs, at least 10 embryos 
from the clutch were used to generate each time point. The data represents an average from 
studies in 3 clutches of eggs. 
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Figure 4.2.2- Cumulative survival curve following LARP7 genetic knockdown. Zebrafish eggs from 
the same clutch were injected at 1-4 cell stage with LARP7 morpholino mismatch, splice or 
translation blocking. Surviving embryos were counted at 6, 24, 48, 72, 96 and 120 hpf. Non-injected 
group represent a basic control to for the egg quality. N=3 experiments, at least 50 embryos were 













4.2.3.2.3 Effect of  MO-LARP7 injection on gross and cardiac 
phenotype 
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4.2.3.2.4 Effects of MO-LARP7 on cardiac growth, function and 
cardiomyocyte proliferation 
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Figure 4.2.3 – Effect of MO-LARP7 injection on the LARP7 expression. LARP7 mRNA (A) 
level was assessed at 48 and 96 hpf, protein (B) level was assessed at 48 hpf. mRNA and 
protein were significantly reduced following injection of MO-CDK9splice blocking and MO-
CDK9 translation blocking, respectively. Panel C shows western blot membranes following 
ECL detection. ß-actin was used to normalize mRNA level, while tubulin was used to 
normalize protein level. N=3 experiments, **=p<0.01, ***=p<0.001, one-way ANOVA test 































Figure 4.2.4- Characterisation of the 72 hpf zebrafish embryo and cardiac phenotype following LARP7 
morpholino treatment. Each diagram report on the X axis a specific trait, which phenotypic severity 
increase from left to right. On the Y axis is reported the percentage of embryos retaining that phenotype. 
The first two diagrams, with body axis and head shape, explain the embryo body phenotype while lower 
diagrams, with tail blood flow, pericardial edema, heart shape and heart rate, are related to the cardiac 
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Figure 4.2.5a – Effect of MO-LARP7mismatch injection on the zebrafish embryo. Zebrafish 
eggs were injected at 1-4 cell stage with this control morpholino. A shows an overall view of 
embryos at 72 hpf under white light. B is the same image captured under fluorescence light 
to show the successful injection by the morpholino-linked red lissamine (white star). One of 
the embryos is shown at higher magnification in C. Image D  shows an H&E stained 
embryo, while E shows a still image from a video of an in-vivo beating heart. Key: BA - 





























Figure 4.2.5B – Effect of MO-LARP7splice blocking injection on the zebrafish embryo. 
Zebrafish eggs were injected at 1-4 cell stage with this control morpholino. A shows an 
overall view of embryos at 72 hpf under white light. B is the same iamge captured under 
fluorescence light to show the successful injection by the morpholino-linked red 
lissamine (white star). One of the embryos is shown at higher magnification in C. D 
shows an H&E stained embryo section, E shows a still image of the heart captured from 

























Figure 4.2.5C – Effect of MO-LARP7 translation blocking injection on the zebrafish 
embryo. Zebrafish eggs were injected at 1-4 cell stage with this control morpholino. A 
shows an overall view of embryos at 72 hpf under white light. B is the same iamge 
captured under fluorescence light to show the successful injection by the morpholino-linked 
red lissamine (star). One of the embryos is shown at higher magnification in C. D shows an 
H&E stained embryo section, E shows a still image of the heart captured from a video of 
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Figure 4.2.6 - Effects of LARP7 genetic knockdown on cardiac structure and function. 
Embryo eggs 1-4 cell stage from the same clutch were injected with MO-LARP7 splice or 
MO-LARP7 translation blocking or MO-CDK9 mismatch. Ejection fraction (A), Total ventricle 
cardiomyocyte number (B) and Ventricle (C) and Atrial (D) diastolic area were assessed in 
zebrafish embryonic heart at 72, 96 and 120 hpf. Cardiomyocyte analysis is reported only 
for  MO-LARP7splice embryonic heart. N=3 experiments, *=p<0.05, two-way ANOVA test 
for repeated measures was used to assess difference between means, excluding 












Figure 4.2.7 – Effects of LARP genetic knockdown on the gene expression. Embryo eggs 1-4 
cell stage from the same clutch were injected with MO-LARP7 splice blocking or MO-LARP7 
mismatch. At 48 and 96 hpf mRNA was extracted from whole embryos (at least 10 embryo per 
group). Level of CDK9 mRNA and relevant gene for cardiac development GATA4, 5 and 6, 
MEF2c, TBX5 mRNA was detected by Q-PCR analysis. mRNA level were normalised to the 
housekeeping gene ß-actin. N= 3 experiments, *=p<0.05, two-way ANOVA test followed by 































































































































Figure 4.2.8 Effects of CDK9 and LARP7 knockdown on the Phosphorylation of Ser2-
CTD. Western blotting membranes showing the level of PosphoSer2-CTD in the zebrafish 
whole embryos 72 hpf, tubulin was used as loading control. Embryo eggs 1-4 cell stage 
were injected with MO-CDK9 mismatch or splice blocking or were injected with the MO-
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Development and validation of a heart 
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5.2.1 Heart laser injury protocol 
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5.2.1.1 Single pulse injury 
](! P0(L+5! /Q+P5! <-*10-<! 0(VQ*K! 6N0LQ*5! AR"9?! )S'! 10NN5*5()! +-P5*! PKP)5IP! S5*5!
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T0<*'J5-I!6P5<)0'(!#RDR"9!-(1!)M5!id&+'(5!+-P5*!-J+-)'*!6P5<)0'(!#RDR#9R!
5.2.1.2 Intra-cardiac structures injury  
7'! -PP5PP! )M5! *5P/'(P5! )'! 0(VQ*K! 0(! 10NN5*5()! .5()*0<+5! *5L0'(P?! )M0P! S-P! 10.0151!
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5.2.1.3 Multi-pulses injury 
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5.2.2 Optical Gating System  
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5.2.4 Exposure of embryos to drugs 
5.2.4.1 Exposure to Aphidicolin 
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J-)M51!N*'I!#@!M/N!0(!5IJ*K'!I510QI!<'()-0(0(L!$>!fT!-/M010<'+0(!6;K'(P!"#!$%&?!
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5.2.5.1 Cardiomyocyte number analysis 
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5.2.7 Statist ical analysis 





































Figure 5.1- Cardiac laser injury. Zebrafish embryos 72 hpf (lower panel) were used for all 
experiments of laser injury. The laser pulse was delivered to the area of the ventricle 
indicated by the red dot (Panel A) and resulted in a clear burn-mark at the point of injury 
(Panel B), see also supplementary movie 1 (V – ventricle, BA – bulbus arteriosus, At – 
























5.3.1 Effects of a single laser pulse to the ventr ic le  
5.3.1.1 Heart function and cardinal vein blood f low 
O! P0(L+5! +-P5*! /Q+P5! )'! )M5! I013<-.0)K! 'N! )M5! .5()*0<+5! *5PQ+)51! 0(! 0(P)-()-(5'QP!
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Figure 5.2- Effects of a single laser pulse on cardiovascular function. Data presented here were 
obtained from embryos injured with the PALM laser system at 72 hpf. A. Images captured under 
fluorescence microscope with a B&W video camera showing the same zebrafish embryonic heart 
ventricle before laser injury, at 2h and 24h post-laser injury. Embryos were maintained at 28.5°C 
between the measures. B-E Heart rate, cardinal vein blood velocity, ejection fraction and ventricle 
diastolic area were assessed before laser and 2, 24, 48h post-laser injury (Mean±sem, N=5 
experiments). **=p<0.05, ***=p<0.001, two-way ANOVA test for repeated measures was used to 




















Table 5.1- Comparison of the PALM Microbeam and XYClone Ablator systems. Single laser pulse 
injury to the mid-ventricle from each laser system resulted in similar changes in ejection fraction, 
heart rate, ventricle diastolic area and cardiomyocyte number at 2h and 24h post-laser 




5.3.1.2 Cardiomyocyte number analysis 
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'JP5*.51! -! P)-)0P)0<-++K! P0L(0N0<-()! I5-(! "CX! *51Q<)0'(! 0(! )M5! (QIJ5*! 'N!
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5.3.1.3 Histo logy  
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S-P! /*5P5()! S0)M0(! )M5! /5*0<-*10-+! P/-<5R! O/'/)')0<! (Q<+50! S5*5! *5<'L(0`51! -P!
PM'S(!JK!O<*010(5!U*-(L5!P)-0(0(L!6N0LQ*5!AR@!%9R!O)!#@M!/'P)3+-P5*!0(VQ*K!-+)M'QLM!
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Figure 5.3- Effect of a single laser pulse on total and proliferating ventricle cardiomyocyte number. 
Panel A. DAPI stained nuclei counted as total number of ventricle cardiomyocytes (TVCn) in 
cmlc2:EGFP hearts, shown in the lower panel (B). C. PhosphoHistone H3 stained nuclei, in red, 
represent proliferating cardiomyocytes (PVCm). Total (D) and proliferating (E) ventricle 
cardiomyocyte number variations during normal development, from 72 to 120 hpf (48 h post-
laser), and following laser injury (Mean±sem, N=5 experiments, *= p<0.05, two-way ANOVA test 






















































































Figure 5.4 - Histological and apoptotic cell assessment of zebrafish heart ventricle laser injury. Panel 
row A. Haematoxylin and Eosin staining showing apoptotic/necrotic bodies in the area of laser damage 
(black arrowhead) at 2h post-laser injury and their absence at 24h post-laser injury. Laser-injury also 
resulted in a reduction in thickness of the mural myocardium at 24h post-laser (black arrowhead). Panel 
row B. Whole mounted zebrafish embryos (Wik wild type strain), stained with acridine orange, show 
positive nuclei at 2h post-laser (white arrows) in the area of laser injury. No apoptotic/necrotic bodies 
were detectable before laser or at 24h post-laser in the site of injury. Panel row C. Whole mounted 
zebrafish embryonic hearts following TUNEL assay, showing apoptotic bodies at 2 h post-laser (white 
arrows) in the area of laser injury. Few apoptotic bodies were detectable before laser or at 24 h post-
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5.3.2 Effects of multip le laser pulse in jury 
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QP51! N'*! )M5P5! 5Y/5*0I5()PR! ](<*5-P0(L! )M5! (QIJ5*! 'N! +-P5*! /Q+P5P!S-P! -PP'<0-)51!
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5.3.3 Effects of laser injury to di fferent heart  
regions 
5.3.3.1 Effects of regionally targeted single laser pulse injury to 
the zebrafish embryo heart ventricle.  
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Table 5.2- Effects of multiple laser pulses on the zebrafish embryo heart ventricle. Effects of 
increasing number of laser pulses (1 to 5) on ejection fraction and ventricle cardiomyocyte number 
at 2, 24 and 48h post-laser injury. Laser-Optical Gating System system allowed multiple laser 
pulses injury in the same ventricle area, with each pulse delivered in the diastolic phase 
(mean±sem, N=16, 3 experiments, *= p<0.05 compared to control at 2h post-laser, one-way 
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5.3.3.2 Effects of single laser pulse injury to the atrioventricular 
cushions and bulbus arteriosus 
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5.3.4 Effects of pharmacological agents on 
response to cardiac laser in jury  
5.3.4.1 Aphidicolin 
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Figure 5.5 – Effects of laser injury to different heart regions. A. Effects of regionally-targeted 
single laser pulse injury in the zebrafish embryo heart ventricle. Heart ventricle was injured into 
three different ventricle regions: basal (B), middle (M) and apical. The diagram shows the heart 
rate before laser, 2h and 24h following laser injury to the 3 specified zones of the ventricle. B. 
Effects of single laser pulse injury in the atrioventricular cushion. Ventricle : atrium heart rate 
ratio was used as a marker of AV block, following laser injury to the AV cushions. Data were 
presented as mean±sem, N=2 experiments, p<0.05, ANOVA followed by Bonferroni’s post-hoc 
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Figure 5.6 - Effects of cell cycle inhibition on cardiac recovery following laser injury in 
zebrafish embryonic hearts. Embryos from the same clutch of eggs were continuously 
exposed to Aphidicolin 30µM from 24 to 120 hpf. Some embryos were laser-injured at the mid-
ventricle at 72 hpf and ejection fraction (diagram A) and ventricle cardiomyocyte number 
(diagram B) were assessed before laser and then at 2, 24 and 48 h post-laser injury. 















 5.3.4.1 Colchicine 
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Figure 5.7- Effects of Colchicine 100!M on the ventricle diastolic area in 
zebrafish embryonic heart following cardiac laser injury. Embryos from the 
same clutch of eggs were continuously exposed to Colchicine 100!M 
from 24 to 120 hpf. Some embryos were laser-injured at the mid-ventricle 
at 72 hpf and ventricle diastolic area was assessed before laser and then 
at 2, 24 and 48 h post-laser injury. (mean±sem, N=3 experiments, 
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5.4.1 Development of a novel cardiac laser in jury 
model 
5.4.1.1 Comparison of three different approaches 
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5.4.1.2 Zebrafish embryonic ventricle recovers following laser 
injury  
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5.4.1.3 Cardiomyocyte proliferation drives the functional recovery 
of injured ventricles 
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5.4.1.4 Effects of multiple laser pulses into the embryonic ventricle 
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5.4.1.5 Effect of pharmacological agents on the recovery ability 
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5.4.2 Additional applicat ions of the Laser-Optical  
Gating System in the zebrafish embryo heart 
5.4.2.1 Laser-induced occlusion of cardiac outflow as a model of 
volume and pressure overload 
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5.4.2.2 Laser-induced injury into the atrioventricular cushion as a 
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Effects of inhibition and derepression 
of CDK9 on the embryonic heart 
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6.2 Methods  
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6.2.1 Cardiovascular function and cardiomyocyte 
analysis 
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6.2.3 Pharmacological treatment of embryos  
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6.2.4 Gene expression analysis 
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6.2.5 Laser technique 
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6.3.3 Effect of CDK9 modulat ion fo llowing cardiac 
laser in jury 
6.3.3.1 Expression of CDK9 in the whole embryo following cardiac 
laser injury 
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6.3.3.2 Cardiac function and cardiomyocyte number in CDK9 
knockdown embryos following laser injury  




HIJ*K'P! 0(V5<)51! S0)M! TU3&8FE! I0PI-)<M! PM'S51! P0I0+-*! /-))5*(! 0(! H,! -(1!
7G&(!<'I/-*51!)'!<'()*'+!('(30(V5<)51!-+)M'QLM!)M5!*5<'.5*K!-)!#@!M!/'P)3+-P5*!S-P!
(')!<'I/+5)5R! ](!5IJ*K'P! 0(V5<)51!S0)M!TU3&8FE!P/+0<5!J+'<W0(L?! 0(P)5-1?! )M5!H,!
S-P! P0L(0N0<-()+K! *51Q<51! -(1! 7G&(! P+0LM)+K! *51Q<51! <'I/-*51! )'! TU3&8FE!
I0PI-)<M!-(1!<'()*'+!('(30(V5<)51!M5-*)P!)M-)!M-1!J55(!+-P5*51!6N0LR!BR#!O!^!%9R!O)!
#@!M!/'P)3+-P5*!0(VQ*K!TU3&8FEP/+0<5!0(V5<)51!5IJ*K'P!101!(')!PM'S!-(K!*5<'.5*K!











































Figure 6.1- CDK9 gene expression in the zebrafish whole embryo following 
cardiac laser injury. Q-PCR was performed before laser and then at 10 min, 1 h, 3 
h  and 24 h post laser injury. This experiment was performed once, therefore no 
statistic analysis was done. Although more experiments are needed to 
corroborate these data, in the future this experiment should be possibly done in 
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6.3.3.3 Cardiac function and cardiomyocyte numbers in LARP7 
knockdown embryos following laser injury 
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Figure 6.2- Effects of CDK9 modulation combined to cardiac laser injury in the zebrafish embryonic heart. CDK9 was inhibited genetically (A-B) by 
injection of MO-CDK9 splice blocking 100 !M (0,5nL per embryo) in eggs at 1-2 cell stage, or pharmacologically (C-D) by continuous exposure to 
flavopiridol 3µM from 24 up to 120 hpf. CDK9 was genetically upregulated (E-F) by injection of MO-LARP7 splice blocking 200 !M (0,5nL per embryo). 
Ejection fraction and cardiomyocyte number analysis were performed before laser and then at 2 and 24 h post-laser injury. N=3 experiments, two-way 
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7.1 Role Of CDK9 In Cell  Division And Growth 
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7.2 Role Of CDK9 During Embryonic 
Development 
+,/2),4!+678!,4')0)'D!)*!&5/G,@@D!()1(.*'!)&!.GI/D5&)4!@)3.!,&2!2.4/.,*.*!,3'./!I)/'(!
JL,&5!,&2!L4(&.)2./M! "##WS! )&!G,GG,@*E! %&'./.*')&1@DM!?.! *(5?.2! )&! '(.!T.I/,3)*(!
'(,'! +678! )*! G5/.! *'/5&1@D! .H-/.**.2! )&! '(.! 3)/*'! 8\(-3! 53! .GI/D5&)4! (.,/'!
2.0.@5-G.&'! ?(.&! 4,/2)5GD54D'.! -/5@)3./,')5&! /,'.! ?,*! ()1(./E! F()*! -5*.2! '(.!
[B.*')5&!,*!'5!?(.'(./!+678!G,&)-B@,')5&!)G-,4'.2!5&!4,/2)5GD54D'.!-/5@)3./,')5&!
2B/)&1!.GI/D5&)4!2.0.@5-G.&'!,&2!*BI*.[B.&'@D!5&!4,/2)50,*4B@,/!3B&4')5&E!
F5! ,**.**! '()*M! %! [B,&')3).2M! 35/! '(.! 3)/*'! ')G.M! 2.',)@.2! 4(,/,4'./)*')4*! 53!
4,/2)5GD54D'.!&BGI./!,&2!G)'5')4!/,'.!)&!'(.!T.I/,3)*(!.GI/D5&)4!(.,/'!0.&'/)4@.!)&!

















*)T.M! (.,/'! /,'.! ,&2! 4,/2)&,@! 0.)&! I@552! 3@5?! 4(,&1.*! 2B/)&1! '(.! 3)/*'! N"#(-3! ,&2!
.H-@5/.2!-5'.&'),@!/.@,')5&*()-!,G5&1!'(.*.!3,4'5/*E!%!2.G5&*'/,'.2!'(,'!I.'?..&!8\!
,&2! N"#! (-3M! )&! *-)'.! 53! '(.! ()1(.*'! 4,/2)5GD54D'.! -/5@)3./,')5&! /,'.M! '()*!?,*! &5'!
,**54),'.2!?)'(!,!45&45G)',&'!)&4/.,*.!)&!0.&'/)4@.!2),*'5@)4!,/.,M!,!G.,*B/.!53!(.,/'!
1/5?'(M!,*!5I*./0.2!)&!'(.!3)/*'!8\!(5B/*!53!2.0.@5-G.&'E!F(.*.!3)&2)&1*!*B11.*'!'(,'!
)&4/.,*.*! )&! 4,/2)5GD54D'.! 4.@@! &BGI./! ,&2! )&4/.,*.*! )&! (.,/'! *)T.! 25! &5'! 544B/!
45&'.G-5/,&.5B*@D!,&2! '(,'!-./)52*!53! (D-./-@,*')4! 1/5?'(!,/.! )&'./A*-./*.2!?)'(!
(D-./'/5-()4!1/5?'(E! !VB/'(./G5/.M! '(.*.!2.0.@5-G.&',@!*',1.*!?./.!4(,/,4'./)T.2!
ID! ,! 1/,2B,@! ,&2! -/51/.**)0.! )&4/.,*.! )&! 4,/2),4! 5B'-B'M! ,*! ,! /.*B@'! 53! )&4/.,*)&1!
(.,/'! /,'.M! )G-5/',&'! '5! 450./! '(.! )&4/.,*)&1!G.',I5@)4! 2.G,&2*! 53! &.?@D! 35/G)&1!
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-/5@)3./,')5&M!4,/2),4!3B&4')5&!,&2!',)@!I@552!3@5?E!F,I@.!=EN!,&2!=E"!*(5?!,!*BGG,/D!
53!'(.!.33.4'*!53!+678!G52B@,')5&!5&!G5@.4B@,/!/.1B@,')5&M!4,/2)50,*4B@,/!3B&4')5&!
,&2! 4,/2)5GD54D'.! -/5@)3./,')5&! 2.*4/)I.2! )&! '()*! '(.*)*E! R.! 35B&2! '(,'! '(.! '?5!




45&3)/G! '(,'!?()@.!+678M!5/! '(.! <AFUVI! 45G-@.H! )*! .**.&'),@! 35/! '(.! .H-/.**)5&!53!
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/.-5/'! *B11.*'*! '(,'! 4./',)&! 1.&.*! ?)'()&! '(.! -X$! -,'(?,D! ,/.! ,I@.! '5! ID-,**! '(.!
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7.3 CDK9 As A Pharmacological Therapeutic 
Target For Heart Disease 
7.3.1. Switching I t Off ! 
+678!,4')0)'D! )*!,4'B,@@D!I.)&1!.0,@B,'.2! )&!-/.A4@)&)4,@!,&2! 4@)&)4,@! *'B2).*! 35/! '(.!
'/.,'G.&'! 53! 4,/2),4! (D-./'/5-(DM! ,&2! *.0./,@! 5'(./! -,'(5@51).*M! ?(5*.! -/)&4)-,@!























Table 7.1 - Summary of the effects of the CDK9 modulation on the zebrafish embryo gene and protein 
expression.!
Treatment! Gene expression! Protein expression!
! GATA4! GATA5! GATA6! MEF2c! TBX5! NKX2.5! CDK9! LARP7! CDK9! LARP7! CTD!
Flavopiridol! !!!!"! !!!""! !!""! !!!!"! !!!!!! !!!""! !!!!! !!!!! !!""! ! !!!
MO-CDK9! !!!!#! !!!!#! !!!!!! !!!!!! !!!#! ! !!!! !!!#! !!!! ! !!!
MO-LARP7! !!!#! !!!!#! !!!!#! !!!#! !!!"! !!!#! !!#! !!!! ! !!!! #!
Table 7.2 – Summary of the effects of the CDK9 modulation on the global zebrafish embryo and on the 






67! 89! 3:;7! :<=! =<=! >:32!
Flavopiridol! !!!!?! !!!!!!!!?! !!!!!??! !!! #! !!!!!!! !!!!!!!! !!!!!!! !!!!!!
MO-CDK9! !!!???! !!!!!???! !!!!???! !!!! #! !!!!!!! !!!!!!!! !!!!!!! !!!!!!!
MO-LARP7! !!!!!?! !!!!!!!?! !!!!!!?! #! #! !!!!#! !!!!!!#! !!!"""! !!!!!"!
Degree of mortality or phenotype: (+) mild, (++), medium or (+++) severe. Effect on Cardiovascular function: (",!) mild, 
("",!!) medium or (""",!!!) strong increase/decrease or (#) unchanged 






$%! &'()*+,-,.*'! /+-01/'(20%! 1030! 04+-0%%,*35! ,2! ,%! ,6+*-2(32! 27(2! 80! 9/'':!
/3.0-%2(3.! 270! 6*'0;/'(-! +(278(:%! <:! 87,;7! &'()*+,-,.*'! +-*./;0%! 270%0! 0990;2%!
=9,1/-0!>?#!$@?!A3.00.5!/+-01/'(2,*3!*9!1030%!,3;'/.,31!2-(3%;-,+2,*3!9(;2*-%!B$C$!D5!










+-*',90-(2,*3! ),(! B$C$S-0'(20.! +(278(:%?! A2! ,%! +*%%,<'0! 27(2! HLMN! G3*;G.*83!
(;2,)(20%! (! 900.<(;G! '**+! 27(2!/+-01/'(20%! 270%0! 2-(3%;-,+2,*3! 9(;2*-%!87,;7! ,3! 2/-3!
(2206+2!2*!-00%2(<',%7!3*-6('!;(-.,*6:*;:20!3/6<0-!(3.!;(-.,*)(%;/'(-!9/3;2,*3?!
7.3.2 Switching I t On!  
K3! 270! *270-! 7(3.5! T$UV>! G3*;G.*83! =9,1/-0! >?#! W@! +-*)*G0.! (3! ,3;-0(%0! ,3!
)032-,;'0! ;(-.,*6:*;:20! 3/6<0-5! ('27*/17! 3*2! (;;*6+(3,0.! <:! (3! ,3;-0(%0! ,3! 270!
)032-,;'0! ;7(6<0-! %,X0! %/110%2,31! (! 6*-0! +-0.*6,3(32! 7:+0-+'(%2,;! -0%+*3%0?!
T$UV>!%+0;,9,;('':!<,3.%! 2*!(3.!037(3;0%! 270!%2(<,',2:!*9! 270!;*6+'04!>QM!%3UY$S
Z[\A]SHLMN?! C70! 7:+*270%,%! 8(%! 27(2! 27,%! ,37,<,2*-:! ;*6+'04! 8*/'.! ;*''(+%0!
9*''*8,31!T$UV>!G3*;G.*83!(3.!%/<%0P/032':! ,3;-0(%0!HLMN!(;2,),2:?! A!*<%0-)0.!
,3! 9(;2! 27(2!T$UV>!G3*;G.*83!+-*./;0.!(!+-*9*/3.!,3;-0(%0! ,3! 270!(2-,('!;7(6<0-!
%,X0?!&*-!20;73,;('!-0(%*3%!A!;*/'.!3*2!(;;/-(20':!(%%0%%!(2-,('!;(-.,*6:*;:20!3/6<0-5!






7.4 Role Of CDK9 In Response To Injury 





,3! 270!X0<-(9,%7! 06<-:*3,;! 70(-2! )032-,;'0?!C7,%! 7,17! 27-*/17+/2! 06<-:*3,;!6*.0'!





3/6<0-! *9! ;(-.,*6:*;:20! (3.! ,3;-0(%0.! (+*+2*%,%! ,3! 270! (-0(! *9! ,3^/-:! 87,;7!





`-01030-(2,*3a?!C70!-01030-(2,*3! ,%!;7(-(;20-,X0.!<:!(! %0-,0%!*9!0)032%! 27(2!/39*'.%!
-0%/'2,31!,3!-0(;2,)(2,*3!*9!(!902('!1030!+-*1-(6?!C70!-0+(,-!+703*603*3!*<%0-)0.!,3!
270! X0<-(9,%7! 06<-:*3,;! 70(-2! *;;/-%! 8703! 270! 902('! 1030! +-*1-(6! ,%! ('-0(.:! ,3!
*+0-(2,*3!(3.!(%!%/;7!270%0!;(-.,*6:*;:20!(-0!3*2!:02!9/'':!.,990-032,(20.?!
A2!8*/'.! <0! ,3(++-*+-,(20! 270-09*-0! 2*! /%0! 270! 20-6! -01030-(2,*3! ,3! 27,%! ;(%0?! C7,%!
%2/.:! ;*39,-6%! 270! ,6+*-2(3;0! *9! %2/.:,31! 6*'0;/'(-! +-*;0%%0%! 27(2! *-;70%2-(20!
*-1(3!.0)0'*+6032!(3.!2*!*<%0-)0!270!=-0@1030-(2,)0!+-*;0%%0%!*9!(./'27**.!9-*6!(!
.,990-032!+0-%+0;2,)0!=$'04(3.0-!(3.!W-/30(/5!"I#I_!]0-;*'(!"#!$%&5!"I##@?!!
A! 7:+*270%,X0.! 27(2! 270! X0<-(9,%7! 06<-:*3,;! 70(-2%! 9*''*8,31! '(%0-! ,3^/-:! ;*/'.!





Figure 7.1- Two possible models to explain the opposite role of the CDK9. A. Following CDK9 inhibition 
by pharmacological (or genetic) agents, a feedback loop activate gene expression by a hitherto undefined 
mechanisms. B. Following knockdown of the CDK9 repressor LARP7, the inactivation of the CDK9-
inhibitory complex increase CDK9 activity and promote RNA synthesis and cell growth. In the zebrafish 


















































































































































































































T$UV>! G3*;G.*83! /+-01/'(20! HLMN! (3.! ,3;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!
T$UV>! G3*;G.*8 ! /+-01/'(20! HLMN! (3.! , ;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!
T$UV>! G3*;G.*83! /+-01/'(20! HLMN! (3.! ,3;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!
T$UV>! G3*;G.*8 ! /+-01/'(20! HLMN! (3.! , ;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!
T$UV>! G3*;G.*83! /+-01/'(20! HLMN! (3.! ,3;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!
T$UV>! G3*;G.*8 ! /+-01/'(20! HLMN! (3.! , ;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!
T$UV>! G3*;G.*83! /+-01/'(20! HLMN! (3.! ,3;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!
T$UV>! G3*;G.*8 ! /+-01/'(20! HLMN! (3.! , ;-0(%0! ;(-.,*6:*;:20!
+-*',90-(2,*3!
!














































































































































T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!
T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!
T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!
T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!
T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!
T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!
T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!
T$UV>! G3*;G.*83! /+-01/'(20%! HLMN! (3.! ,3;-0(%0! %;(-.,*6:*;:20!
+-*',90-(2,*3
!






















R703!270! '(%0-! ,3^/-:!8(%!(%%*;,(20.!8,27!HLMN!6*./'(2,*35!-0;*)0-:! ,3!)032-,;'0!
9/3;2,*3!8(%!*3':!*<%0-)0.!8703!T$UV>!8(%!-0./;0.!<:!6*-+7*',3*!G3*;G.*83?!
C7,%! %/110%2%! 27(2! -0./;0.! HLMN! (;2,),2:! *-! '(;G! *9! HLMN! ,37,<,2%! -0;*)0-:! (920-!
'(%0-!,3^/-:!(%!(!-0%/'2!*9!('20-0.!;(-.,*6:*;:20!+-*',90-(2,*3?!T$UV>!G3*;G.*83!*3!
270! *270-! 7(3.! .,.! 3*2! %,13,9,;(32':! (990;2! ;(-.,(;! -0;*)0-:5! 87,;7! 8(%! %,6,'(-! 2*!




<0! 9/-270-! 04+'*-0.?! &*-! 04(6+'05! ;*3%,.0-,31! 27(2! 270! ,3(;2,)0! VSC[&<! ;*6+'04!
,3;'/.0%!Z[\A]!(3.!>QM5!;*S,37,<,2,31!28*!*-!6*-0!*9!270%0!HLMN!-0+-0%%*-%!;*/'.!
<0! (! +-*6,%,31! 270-(+0/2,;! %2-(201:?! &*''*8,31! ,3^/-:5! 6(66(',(3! 70(-2%! .,%+'(:!
%*60!*9!270!2,%%/0c;0''/'(-!-0(;2,*3%!2:+,;('!*9!;(-.,(;!-01030-(2,*3!</2!,3!(!8(:!27(2!
,%! /3(<'0! 2*! -0+(,-! 04203%,)0! ;(-.,(;! .(6(10?!d3.0-%2(3.,31! *9!HLMN!6*./'(2,*3!
6(:! (''*8! ('20-3(2,)0! 270-(+0/2,;! (++-*(;70%! 2*! 70'+! (..-0%%! 70(-2! 9(,'/-0! ,3!
7/6(3%!=](-2,3SV/,1!"#!$%&5!"I#"@?!
7.6 Limitations of the work in this thesis  
$2!270!03.!*9!6:!270%,%5!A!7()0!-0(',X0.!27(2!A!8*/'.!;7(310!*-!,6+-*)0!%*60!(%+0;2%!
*9! 6:! %2/.,0%! ,9! 27,%! 8(%! 2*! <0! -0+0(20.?! &*-! 9/2/-0! 6*-+7*',3*! 04+0-,6032%5! 9*-!
04(6+'05!A!8*/'.!(..!6*-0!;*32-*'%!0,270-!<:!+0-9*-6,31!e-0%;/0f!04+0-,6032%!8,27!
6UY$! =%00! ! %0;2,*3! #?E?O?"! 9*-! (! .02(,'0.! 04+'(3(2,*3@! *-! <:! ,3^0;2,31! 270! +EO!
6*-+7*',3*! 2*! (%%0%%! 270! +EOS.0+03.032! (+*+2*%,%?! C7,%! %7*/'.! 1,)0! 6*-0!
;*39,.03;0!27(2!270!+703*2:+0!*<%0-)0.!,3!270!X0<-(9,%7!06<-:*!,%!103/,30':!-0'(20.!
2*!6:!2(-1020.!1030?!
A!8*/'.! ,6+-*)0! 9'()*+,-,.*'! *+2,6,X(2,*3! <:! .*,31! (! ;/-)0! .*%0S0990;2!870-0! 9*-!
0(;7!,3;-06032!,3!270!;*3;032-(2,*3!*9!.-/1!A!8*/'.!(%%0%%!270!'0)0'!*9!+7*%+7*SQ0-"5!
9*-!87,;7!270!(32,<*.:!,%!('-0(.:!()(,'(<'0?!A!8*/'.!('%*!60(%/-0!+7*%+7*SHLMN5!'&"&!
270! (;2,)(20.! 9*-6! 27(2! %7*/'.! <0! -0./;0.! 9*''*8,31! 04+*%/-0! 2*! 9'()*+,-,.*'5! ,9! (!
1**.!(32,<*.:!8*/'.!<0!()(,'(<'0?!!







C7,%! 6027*.! 1,)0%! .02(,'0.! ,39*-6(2,*3! *3! 270! 2*2('! 3/6<0-! *9! ;0''%! 27(2! +(%%0.!
27-*/17! Q! +7(%0! ,3! (! %0'0;20.! 2,60! 8,3.*8?! A3! 6:! 04+0-,60325! 9*-! 04(6+'05! 270!
04+*%/-0!*9! ;(-.,(;! ,3^/-0.!*-! 3*3S,3^/-0.!06<-:*%! 2*! 270! W-.d! ,660.,(20':!(920-!
'(%0-!.0',)0-:!8*/'.!1,)0! ,39*-6(2,*3!*3!270!3/6<0-!*9!;(-.,(;!;0''!;:;'0!/+!2*!"!7!
+*%2S'(%0-!*-!*270-!%0'0;20.!2,60?!
7.5 Future work 
]:!9,3.,31%!7,17',172!270!300.!9*-!9/-270-!%2/.,0%!*9!HLMN!,3!6(66(',(3!6*.0'%?!$!
9,-%2!%20+!;*/'.!<0!%2/.:,31!270!HLMN!04+-0%%,*3!+(220-3!,3!6,;0!30*3(2('!70(-2!(3.!
(3(':%,31! ,2%! -*'0! ,3! 270! -01030-(2,31! (<,',2:! 9*''*8,31! ;(-.,(;! (+04! -0%0;2,*3!
=V*--0''*! "#! $%&5!"I##@?!C703!6*)0!HLMN! %2/.,0%! ,3! 270!(./'2!6(66('%?! A2!8*/'.!<0!
)0-:! ,6+*-2(32! 2*! /3.0-%2(3.! 870270-! 270! 70(-2! %:3270%,X0%! (! %+0;,9,;! HLMN!
,%*9*-65! %*! 27(2! 308! .0)0'*+0.! .-/1%! ;*/'.! <0! 2(-1020.! (2! ;(-.,(;! %+0;,9,;! HLMN!
8,27! '0%%! 0990;2! *3! *270-! *-1(3%! (3.! 2,%%/0%?! V(-2,;/'(-':! ,320-0%2,31! 8*/'.! <0!
,3)0%2,1(2,31!270!0990;2!*9!HLMN!/+-01/'(2,*3!<:!T$UV>!G3*;G.*835!*-!*270-!HLMN!
-0+-0%%*-%5! *3! 270! ;(-.,(;! -06*.0',31! 9*''*8,31! ,%;706,;! ,3^/-:! ,3! 270!70(-25! *-!*3!
30*(31,*1030%,%! ,3! 270! 906*-('! (-20-:! 9*''*8,31! ,%;706,(?! A3.00.5! /+-01/'(2,*3! *9!
HLMN! (2! '0)0'%! %,6,'(-! 2*! 27*%0! *<%0-)0.! ,3!6(66(',(3%! 902('! ',90! ;*/'.! (''*8! 270!
%(60!70(-2!+'(%2,;,2:!27(2!.-,)0%!;(-.,(;!9*-6(2,*3?!C7,%!;*/'.!<0!(!+*80-9/'!2**'!9*-!
+-*(31,*103,;! (3.! %206! ;0''! 270-(+,0%5! 3*2! *3':! <:! .,-0;2':! +-*6*2,31! ;0''!







$<(-<(30''5! $?! ]?5! Z0--6(335! g?! T?5! R0,'5! W?! U?5! R(315! h?5! C(35! g?5! ]*<0-':5! Q?! V?5!
&,0105! g?! R?! i! ]0'.-/65! L?! U?! "I#I?! $3,6('! 6*.0'%! *9! 6:*;(-.,('! (3.! )(%;/'(-!
,3^/-:?!g!Q/-1!U0%5!#F"5!"ONSDN?!
$;G0-6(335! B?! [?! i! V(85! W?! Z?! "IIO?! j0<-(9,%7k! (! 10302,;! 6*.0'! 9*-! )0-20<-(20!
*-1(3*1030%,%!(3.!7/6(3!.,%*-.0-%?!&-*32!W,*%;,5!J5!.#"">SEO?!
$7/^(5! V?5! Q.0G5! V?! i!](;'0''(35!R?! U?! "II>?! H(-.,(;!6:*;:20! ;0''! ;:;'0! ;*32-*'! ,3!
.0)0'*+60325!.,%0(%05!(3.!-01030-(2,*3?!V7:%,*'!U0)5!J>5!E"#SDD?!
$G72(-5!]?!Q?5!Z0,.06(335!]?5!C,02^035!g?!U?5!j7(315!L?!R?5!H7(+6(35!U?!L?5![,;G5!L?!
i!$3%(-,5! $?! j?! "IIN?! C&AAZ! G,3(%0! +'(;0%! <,)('032!6(-G%! *3! 270! ;(-<*4:S20-6,3('!
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